SlideShare a Scribd company logo
Urology infectionUrology infection
Edmond Wong
Outline
• Definition
• Bacteriology
• Cystitis & urethritis
• Recurrent UTI
• Pyelonephritis, EPN & XGP
• General principles of antibiotic and prophylaxis
• Mx of septicaemia
• TB urinary tract
• Prostatitis
• Epididymal orchitis
• Viral disease of Genital tract (condylomata, AIDS, Herpes)
• Schistosomiasis
• Radiation cystitis
• Chemical cystitis and mx
• Antibiotic prophylaxis in uro procedure
Definition
• Bacteriuria: Presence of bacteria in urine
• Pyuria: presence of WBC in urine
• Sterile Pyuria: Pyuria without bacteriuria
1. Incomplete antimicrobial treatment of UTI
2. Infections caused by Mycobacterium tuberculosis
and other fastidious bacteria, e.g. Chlamydia
trachomatis
3. Urolithiasis and foreign bodies
4. CIS
5. Interstitial cystitis
6. schistosomiasis
Definition
• Cystitis:
– Clinical syndrome of dysuria, frequency & urgency +/-
Bladder pain
• Acute pyelonephritis:
– Syndrome of Fever, Chills & rigor, flank pain ,
bacteriuria + pyuria
• Chronic pyelonephritis:
– Radiological diagnosis
– Scarred , shrunkened kidney (may or maynot result
from recurrence infection)
What is the definition of UTI?
• UTI – Inflammatory response of
urothelium to microorganism invasion,
commonly bacteria , associated with
pyuria and bacteriuria
• Opportunistic infection : infection caused
by non-pathogens (commensals) due to
weakened host defence mechanisms
Definition of UTI
• Isolated UTI:
– Occur at least 6m after the previous UTI
• Recurrent UTI : >=2 UTI in 6m / >=3 UTIs in 1yr
– Bacterial persistence: UTI by same organism
• Nidus (stone, bladder/urethral diverticulum, chronic
prostatitis, colo-vesical fistula)
– Reinfection: by different organisms each time
• Increased susceptibility to UTI, e.g. poor hygiene, sexual
intercourse, post menopause
• > 95% female recurrent UTI is reinfection
Definitions of UTI
• Unresolved infection: not response to txn
1. Bacterial resistence to antibiotic
2. Development of resistance in a previously
susceptible organism
3. Multiple organism
4. Rapid re-infection & overwhelming pathogens
5. Subtherapeutic level of antimicrobial
6. Non-compliance with treatment
Definition of UTI:
• Complicated UTI
– Structurally and functionally abnormal urinary tract
– Underlying disease prone to complicated UTI
1. Male gender , elderly
2. Pregnancy
3. Catheter or stent or instrumentation
4. immunocompromised, DM, hospital acquired infection
• uncomplicated UTI
– No structurally and functionally abnormal urinary
tract
– No underlying disease prone to acquire UTI
How does the urinary dipstick –How does the urinary dipstick –
(blood) work?(blood) work?
• Chromogen indicator : orthotolidine is a peroxidase substrate
• Haemoglobin has peroxidase activity
• Oxidation process take place
• Positive result : BLUE
• False positive (oxidasing agent):
1. Povidone iodine
2. Hypochlorite (bleach)
3. Menstrual blood
4. Dehydration, exercise and myoglobin
• False negative (reducing agent):
– Vitamin C
– Poorly mixed urine
• Dipstick positive but microscopy negative – dilute urine
How does the urinary dipstick –How does the urinary dipstick –
(WBC) work?(WBC) work?
• Neutrophils produce leucocyte esterase
• Catalyzes the hydrolysis of a indoxyl carbonic acid ester
to indoxyl
• Idoxyl oxidise the diazonium salt chromogen to produce
blue colour
• False positive : vaginal discharge or formalin
• False negative (reducing agent)
1. Vitamin C
2. Dehydration
3. Glycosuria, urobilinogen
4. Test is read too fast (< 2min) or too long (lysis of WBC)
• 30% of infection with negative leucocyte esterase ( =
70% sensitivity)
How does the urinary dipstick –How does the urinary dipstick –
(nitrites) work?(nitrites) work?
• Gram negative bacteria convert nitrates to nitrites (not usually in
urine)
• Nitrite react with the aromatic amine to form diazonium salt
• Which react with hydroxybenzoquinolone to form pink colour
(Griess reaction) – 4 hours processing
• High specificity but low sensitivity – means +ve  UTI, negative
cannot rule out UTI
• When negative for both nitrites and leukocytes 90% of MSU will
be negative for significant bacteriuria
• When positive for both nitrites and leucocytes, 80% will have
positive cultures on MSU
– More specific but less sensitive to either test alone
• False positive – contamination
• False negative – gram positive bacteria, pseudomonas, ascorbic
acid, and dilute urine, urine in bladder < 4 hours (so only early
morning urine is reliable)
Why is urine pH important?
• Normal urinary pH: 5.5- 6.5
• pH> 7.5  possibility of stone
• Urea splitting organism produce urease: (PKS, PPS)
1. Proteus
2. Klebsiella
3. Staphylococcus
4. Pseudomonas
5. Providencia
6. Serratia
• Induce following reaction:
– Urea  CO2 + NH3 (ammonia)
– NH3 raise pH
– Precipitation of magnesium ammonium phosphate to form
staghorn stone
BacteriuriaBacteriuria
What are the definitions of
significant bacteriuria?
• Kass first introduced quantitative microbiology in
diagnosis UTI
– Significant bacteriuria ≥ 105
cfu/mL of pure growth
– However, miss 1/3 symptomatic UTI with growth ≥ 103
cfu/mLof pure growth
• > 103
: uncomplicated cystitis in women
• > 104
: uncomplicated pyelonephrisitis in women,
catheter urine in women, men
• Asymptomatic bacteriuria should be treated in children,
pregnant female and immunocompromized patents, prior
to an invasive genitourinary procedure for which there is
a risk of mucosal bleeding, but not DM or elderly patient
(Canada’s study)
What is the implication of
bacteriuria?
• A single in/out uretheral catheterization may be
complicated by bacteriuria in 5% of cases
• Bacteriuria is almost universal when the catheter
is left in situ for longer than 3 days
• 10-20% of patients with pyelonephritis have
bacteriuria
• Bacteriuria without pyuria may be found
– bacterial contamination
– Colonization (asymptomatic bacteriuria)
• Absence of pyuria may cause doubt on the
diagnosis of UTI
Risk factor for bacteriuria
1. Female
2. Low oestrogen state (menopause)
3. Pregnancy
4. Age
5. Institutional state in elderly
6. Indwelling catheters
7. Previous UTI
8. DM
9. Stone disease
10.GU malformation & voiding dysfunction (including
obstruction)
How would you instruct the pt for
MSU?
• Women:
– Spread the labia
– Wash and cleanse the periurethral area with moist gauze from back to
front
– Void first 100-150ml , collect next 10-15ml
• Men:
– Circumcised: no special preparation
– Uncircumcised:
• Retract foreskin , wash glans with soap and rinse with water
• Keep foreskin retracted: collect 10-15ml
• Handling of MSU:
– Culture with hours or refrigerated immediately & culture within 24hr
– Microscopy: 5-10ml urine centrifuge for 5min (2000rpm)
– Culture: 0.1ml urine of split-agar plate
• Blood agar  gram +ve culture
• Eosinmethylene blue (EMB)  gram –ve culture
• Estimate CFU after overnight incubation
What is the gram’s stain?
• Bacterial smear is stained with crystal violet for 1-
2min then pour off
• Then Gram’s iodine for 1-2min then pour off
• Decolorized by acetone
• Washed with water and counterstained with safranin
for 2 mins
• Gram +ve: cell wall that retain the crystal violet dye
– MRSA is a gram +ve coccus. It is present on the skin
of about 40% of people. Over 90% of isolates produce
the penicillin binding protein which makes the strain
resistant to penicillin base antibiotics
• G-ve – pink safranin
Pathogenesis of UTI
Why patient will have UTI?
• An interaction of susceptibility of host &
virulence of organism
• Pathogenicity: ability of an organsim to
cause disease
• Virulence: degree of pathogenicity
– Characteristics of uropathogens to colonised
and flourish within the host
Bacterial virulence factors?
• Directed against external agents (i.e
antimicrobial resistence)
– Inherited chromosomally (intrinsic resistance of
proteus to nitrofurnatoin)
• Enzyme inactivation: beta-lactamase which hydrolyses the
beta-lactam bone within penicillin gp of antibiotic
• Secrete by S. aureus , gonorrhoea & enterobacteria
– Acquired chromosomally (mutations)
• Alter the antibiotic target & receptor activity
– Acquire extra-chromosomally (plasmids)
Direct against host:
1. General: extracellular capsule prevent phagocytosis (E coli)
2. Toxin, e.g. haemolysin
3. Enzyme, e.g. urease
4. Antihumoral factors, e.g. IgA inactiviting protein by gonorrhoea and
Proteus
5. Adherence mechanism – afimbrial or fimbrial types (E.coli)
– Afimbrial adhesin – Dr adhesins (UTI in children and pregnancy)
– Fimbriase: 100 pili, 5nm diameter , 2um long
– Type P fimbriae (mannose resistant) have adhesions that bind to renal
urothelium and are associated with >90% of pyelonephritis
– Type P fimbriae are more virulent and more adhesive than type 1 fimbriae
– Type 1 fimbriae (mannose sensitive) binds to elements of bladder urothelium
and are associated with cystitis
– Type 1 fimbriae are also referred to as mannose sensitive. This means that
fimbriae have the ability to adhere to and agglutinate guinea pig erythrocytes.
Such an event is inhibited by mannose
– S pili – both bladder and kidney infection
6. Others
– Penetration of host by schistosoma apine
– Intrinsic resistance of Proteus to nitrofurantoin
What are normal host defence
mechanisms against UTI?
1. Normal commersal flora of vaginal introitus and periurethral
area
– Lactobacilli reduced uropathogens to colonise by lowering pH
as a result of converting glycogen to lactic acid (lower pH)
2. Vaginal oestrogen and IgA
3. Normal antegrade flow of urine
4. Characteristic of urine (high osmolality, low pH, Urea , etc)
5. Mechnical integrity of mucous membrane
6. Normal exfoliation of urothelial cells
7. Tamm-horsfall protein by ascending limb of loop of Henle –
bind type 1 pili & prevent attachment
8. GAG (Glycosiaminoglycan) layer
Route of infection
• Ascending infection (majority)
– Bacteria colonize perineum, vagina & distal urethra
– Ascend to bladder (cystitis)
– Ascend to kidney (pyelonephritis), encourage by
reflux
• Hematogenous (uncommon):
– Staph aureus, candida, fungaemia & TB
• Via lymphatics:
– Inflammatory bowel disease
– Retroperitoneal abscess
Mx of UTI
Anbitiotic Formulary
• TMP-SMX—inhibits dihydrofolic acid reductase
– Enterococcus and Pseudomonas are resistant
• Nitrofurantoin—mechanism unknown
– Pseudomonas and Proteus resistant, not useful in upper tract infections,
development of resistance very low
• Cephalosporins—1st
to 3rd
generation increases Gram negative and
anaerobic coverage
• Aminopenicillins—effective enterococcus, 30% resistance
development in common uropathogen isolates.
• Aminoglycoside—combined with ampicillin 1st
line therapy for
urosepsis, nephrotoxic
• Flouroquinolone—DNA gyrase inhibitor, enterococcus resistant,
damages cartilage in animal studies
Cystitis & urethritis
Uncomplicated Cystitis
• Absence of physiologic or anatomic
abnormalities & no recent urologic surgery
• 30% of women between age 20-40 have had a
UTI
– 80% E. coli
– 15% S. Saprophyticus
• Rarely occurs in men
– Uncircumcised
– HIV
Uncomplicated Cystitis
• Microscopic analysis
is more sensitive than
dip-stick testing
– Bacteriuria
– Pyuria
– Hematuria
Symptoms:
– Dysuria, frequency,
urgency, small urine
volumes, suprapubic
pain
• Differential Diagnosis:
– Vaginitis
– Urethral infection /
urethritis
– STD
Uncomplicated Cystitis
• Pretherapy urine Cx
only for the following:
– Dx in doubt
– Symptoms longer than
7 days
– Older than age 65
– DM
– Pregnancy
– All males
• Treatment (3-days):
– TMP-SMX
– TMP alone
– Nitrofurantoin
– Fluoroquinolones (use
for patients with allergy to
less costly drugs or with
high risk of infection with
resistant organism)
– Amoxicillin-
Clavulanate during
pregnancy
Urethritis
• Inflammation of urethra
• Men: STD with dysuria + urethral discharge
• Gonococcal urethritis (GU)
– gram-negative diplococcus Neisseria gonorrhoea (incubation 10 day)
– concomitant infection with Chlamydia trachomatis
– Investigation: urethral swab for C/ST
– Treatment:
• ceftriaxone 125 mg IM in a single dose
• cefixime 400 mg orally in a single dose
• plus treatment for chlamydia
• Quionolone is not recommended
• Non gonococcal urethritis (NGU)
– Chlamydia trachomatis (incubation 1–5 weeks)
– Azithromycin, 1 g as a single oral dose
– Doxycycline, 100 mg orally twice a day for 7 days
– Transmission to females results in increased risk of pelvic inflammatory
disease, abdominal pain, ectopic pregnancy, infertility, and perinatal
infection
• Gonococci located intracellularly as Gram-
negative diplococci
• Ciprofloxacin (gonococci) and doxycycline
(chlamydial) for 2 weeks if young
epididymoorchitis
• Fluoroquinolones are contraindicated in
adolescents (< 18 years) and pregnant women
Recurrent UTI inRecurrent UTI in
femalefemale
Female refer for recurrent UTI ,
what is your approach?
• History:
– Age
– Isolated or recurrent UTI?
– Trace all previous MSU result
– Re-infection or persistence?
– Number of confirmed UTI in
one year
– Cystitis or pyelonephritis?
– Complicated or uncomplicated
infection?
– Hematuria (CIS)
• PMH:
– Marital and obs hx
– OCP
– STD
– DM
– TB
– Stone
– Constipation
– Neurological illness
– Previous UTI in childhood
• Family hx of UTI
– ABO bld gp Ag non-secretors
– Lewis non-secretor
– P bld gp secretors
PE
• Abd:
– Palpable kidney
– Palpable bladder
– Loin pain
• Vaginal examine:
– State of oestrogenisation
– Genital prolapse
– Urethral diverticulum
• Focused neurological examination
Ix of post-menopausal
Despite all investigation, no
cause of infection identify, what
can you explain to her ?
Why do women increase risk of recurrent
infection?
Susceptibility to infections
1. Increased number of receptors sites for
uropathogen
2. Shorter urethra
3. Close proximity to anus
4. Asymptomatic bacteriuria in pregnant women
5. Large PVR in older women
6. Genital prolapse
7. P blood group secretor / ABO blood group non-
secretor / Lewis non-secretor
8. HLA-A3 phenotype
What are the risk factors ofWhat are the risk factors of
recurrent UTI?recurrent UTI?
1. Reduce antegrade flow of urine (low fluid intake, BOO, neurogenic bladder)
2. Sexual intercourse
3. Use of spermicides
4. Urinary and fecal incontinence
5. Atrophic vaginitis
• Raz (NEJM 1993) published a small randomized trial of 93 post menopausal female
with recurrent urinary tract infections and reported a significant reduction in the
frequency of UTI’s in ladies treated with topical estriol
6. History of UTI
7. Immumocompromised, e.g. DM / HIV
Mx of recurrent UTI : general
measure
Aim: control symptom & reduce frequency of infection
• High fluid intake
• Void before and after sexual intercourse (vigorous
activity may “milk” the bacteria to the bladder)
• Avoid using detergents in her bath
• Avoid using spermicidal contraceptive
• Apply lactobacilli to vagina to keep her urine acidic
• Apply oestrogen to atrophic vagina to restore normal
vaginal environment and recolonisation with lactobacilli
• Cranberry juice (proanthocyanidin) – block bacterial
adherence to urothelium, 20% reduction risk of
infection
Treatment strategies
• < 3 UTI / year: patient initiated therpay
• > 3 UTI/ year: prophylaxis for 6/12
• Post-coital single dose therapy
Mx: Antibiotic
3 regimens available:
• Low dose long-term continuous antibiotics:
– Eliminate introitoal and enteric reservoir, does not cause resistant
– Trimethoprim (100mg) , cephalexin (250mg) ,nitrofurantoin(50mg) QD
– Break thru infection txn with course of A/B, then restart prophylaxis
– 6-12 months, 95% reduction of recurrence, but 60% reinfected after
stopping the antibiotics
• Postcoital antimicrobial prophylaxis
– Ciprofloxacin 125 mg once daily
– Nitrofurantoin 50 mg once daily – lower systemic absorption and less
microbial resistance, but avoided in pyelonephritis as tissue level in
kidney is low
– Avoid amoxicillin and cephalosporin which change fecal flora
• Intermittency self-start therapy:
– Recurrent uncomplicated cystitis
– 3-day course regimen of an antimicrobial with MSU beforehand
– If failed > send MSU for proper culture
– 1 week course if symptom persist or for men
• Trimethoprim:
– Eradicate gram –ve aerobic from gut and vaginal fluid (eradicate
source)
– Batericidal concentration in urine
– Adverse: GI disturbance, mylotoxicity, erythema multiforme,
TEN, photosensitivity
– Cautions in renal impairment
• Nitrofurantonin:
– No effect on gut flora
– High concentration in urine  elimination of bacteria
– Would not induce bacterial resistance
– Adverse: Pulmonary fibrosis , peripheral neruopathy,
agranulocytosis , liver damage
• Cefalexin:
– Would not induce resistance
– Adverse: GI upset , allergic rxn
• Fluoroguinolones :
– Short course eradicate enterobacteria from faecal & vaginal flora
– Adverse reaction: tendon rupture in 48 hour (esp with
concomittent use of steriod) , GI , Steven-Johnson syndrome
Mx if bacterial persistent
• Identify potential cause:
– KUB (stone)
– Renal USG (hydronephrosis, stone)
– FR + RU
– IVU or CTU
– FC (bladder stone, Ca bladder, urethral or
BNS , fistula)
• Txn: treat underlying cause
Acute and chronicAcute and chronic
pyelonephritispyelonephritis
Acute pyelonephritis
• Inflammation of the kidney and renal pelvis
• Presentation:
– Fever, chills rigor
– Flank pain and tenderness
– Lower UTI symptom
– Unilateral or bilateral
• Ddx: cholecystitis, pancreatitis, diverticulitis, apendicitis
• Risk factor:
– Female
– VUR, Urinary tract obstruction or Neuopathetic bladder
– DM, immunocompromised state
– Congenital malformation
– Pregnancy
– Catheter and instrumentation
Acute pyelonephritis
• Pathology:
– Patchy infiltration of neutrophil & bacteria in
parenchyma
– Inflammatory band extending to cortex
– Small cortical abscess (80%)
• Organism: E.coli , enterococci, klebsiella ,
proteus, pseudomonas
• Investigation:
– Bld
– KUB
– MSU
– USG if derange RFT
Radiologic Findings
• Generalized renal enlargement
– Overall length of 15cm
– 1.5cm greater length on the the affected side
• Focal renal enlargement
– Renal mass
• Cortical striations during the nephrogram
phase of the urogram (perinephric
stranding)
• Dilatation of ureter/pelvis
Treatment
• Not systemically unwell : oral
cirprofloxacin 500mg BD for 10 days
• Systemically unwell:
– IVF
– IV antibiotic (quinolone +/- gentamicin)
• Change to oral antibiotic after afebrile
• Complete antitbiotic for 14 days intotal
Is it necessary to perform
upper tract imaging?
• If the patients remain febrile after 72 h of
treatment
• Evaluation of the upper urinary tract with
ultrasound should be performed to rule out
abscess, urinary obstruction
• CTU: pyonephrosis, perinephric abscess ,
emphysematous pyelonephritis, Stone
• Chronic pyelonephritis – scarred shrunken
kidney
What is the antibiotic of
choice?
• Augmentin is not recommended as a drug of first
choice for empirical oral therapy of acute
pyelonephritis. It is recommended when
susceptibility testing shows a susceptible Gram-
positive organism
• In communities with high rates of fluoroquinolone-
resistant and extended-spectrum β-lactamase
(ESBL)-producing E. coli, initial empirical therapy
with an aminoglycoside or carbapenem has to be
considered until susceptibility testing demonstrates
that oral drugs can also be used
Chronic Pyelonephritis
• Dx: Radiologic, Pathologic
– Radiographically scarred & shrunken
• Often no history of UTI
– Bacterial antigens detectable in renal tissue
• Unpredictable association between
infection and renal scarring
• Early antimicrobial treatment decreases
scarring
Chronic Pyelonephritis
• Associated with reflux nephropathy
– Scarring associated with reflux of infected urine
– No scarring with reflux of sterile urine
• 55 Adults with reflux nephropathy
– UTI diagnostic event in 80%
– 20% with enuresis
– 50% with elevated serum creatinine
– 38% had hypertension
– 35% had proteinuria
Chronic Pyelonephritis -
Diagnosis
• Often discovered incidentally
• Azotemia, hypertension, fatigue
• UA: WBC, proteinuria
• Decreased ability to concentrate urine
Chronic Pyelonephritis
• IVU
– Small, atrophic kidney
– Scarring with calyx
clubbing
• VCUG in children
Renal Abscess - Etiology
• Majority are secondary to ascending
gram-negative infection
– Associated tubular obstruction (due to prior
infection or calculi)
• Skin carbuncles or IVDU may lead to
gram-positive abscess formation
• Complicated UTI with associated stasis
due to calculi or neurogenic bladder.
Renal Abscess – Clinical Sx /
Labs
• Symptom:
– Fever , chill , pain
– weight loss, malaise
• Lab: Marked leukocytosis
• UA may be normal, unless there is
communication between abscess and
collecting system
Renal Abscess – Radiologic
findings
• CT of early abscess:
– Renal enlargement
• CT of late abscess:
– Fibrotic wall
– Obliteration of
adjacent tissue planes
– Ring-enhancing
• U/S shows
hypoechoic mass
Renal Abscess - Treatment
< 3 cm: IV ABx & observation
- Serial exam with U/S or CT until resolution
3-5 cm: Percutaneously drain
>5 cm: Surgical I&D
Pyonephrosis
Infected hydronephrosis
associated with
suppurative
destruction of the
kidney parenchyma &
in which there is total
or nearly total loss of
renal function.
Pyonephrosis - Diagnosis
• F/C/Pain
• Lack of bacteriuria indicates complete
ureteral obstruction
• Urographic findings – obstruction
• Infected hydronephrosis always shows
good ultrasonic transmission;
pyonephrosis shows persistent echoes or
a fluid-debris level
Pyonephrosis - Treatment
• Antimicrobial drugs
• Drainage of the infected pelvis (ureteral
cath or perc drain)
• Identify & treat source of infection after
patient becomes hemodynamically stable
Perinephric Abscess
• Located within Gerota’s fascia
• 56% mortality rate
– Delay in Dx (misdiagnosed as acute pyelo)
• Due to hematogenous seeding or from
renal extension of ascending UTI
– Use of antimicrobial therapy has decreased
the chance of hematogenous seeding from
wound and skin infections.
Perinephric Abscess -
Diagnosis
• No pathognomonic abnormalities on any
radiologic examination.
• Decreased renal mobility is the most
specific finding – (Insp/Expir films).
• U/S or CT Scan – Dx &/or Treat
• Treatment: Drainage (surgical vs. perc)
Perinephric Abscess vs. Acute Pyelo
• >5 days of symptoms
prior to hospitalization
• Fevers persist beyond
4 days
• <5 days of symptoms
prior to hospitalization
• No fevers beyond 4
days after appropriate
antibiotics started
SepsisSepsis
What are the definitions of
infection?
What is Systemic inflammatory
response syndrome (SIRS) ?
• Response to infection (sepsis) or non-infection (burn, pancreatitis)
• 2 of the criteria require
What is the pathogenesis of
sepsis?
• Endotoxin release by G-ve bacteria
• Trigger release of mediators, like cytokine,
activation of kinin system, complement
system and fibrinolytic system
• Activation of white cell and macrophages
• Widespread microvascular injury, tissue
ischemia & clinical manifestation
Pt is very unwell , what to do?
• ICU
• Consideration of vasopressor, inotropes,
steriod
• Radiological investigation to identified
source and complication
EmphysematousEmphysematous
pyelonephritispyelonephritis
Case
• F/40
• Good PH
• HPI:
– Acute left loin pain
– Low grade fever
– Vomiting (secondary to paralytic ileus)
• PE:
– BP 120/60, p 110, temp 37.8
– Abd soft, left loin mild tenderness, no mass,
• KUB: no stone
• Urine stix: nitrate+, WBC+, RBC +
• Bedside USG: no hydronephrosis/stone
• CBC: WCC 14, Hb 12
• RFT Cr 100, CaPO4, urate normal
Case
• Imp: Acute pyelonephritis
• IV zinacef
• Progress
– Low grade fever and tachycardia
– Left loin pain slightly improved
– Not septic looking
• DDx?
• Ix?
KUB
CT
EPN causes and pathogenesis
• Acute necrotizing infection of the renal parenchyma and
its surrounding tissues by gas forming organism
• Presence of gas in the renal parenchyma, collecting
system or perinephric tissue
• Most common: Escherichia coli in 70% and Klebsiella
• Others:
– Proteus mirabilis, Group D Steptococcus and CNS
– Anaerobic and rare: Clostridium septicum, Candida albicans,
Cryptococcus neoformans and Pneumocystis jiroveci
• Bacteriaemia: found in 50% EPN, same species as
urine/pus
• Severe, acute pyelo that fails to improve during the initial
3 days of treatment
EPN pathogenesis
• Female: Male = 6:1
• Factors
– High glucose level (DM)
– Gas-forming microbes
– Impaired vascular blood supply
– Reduced host immunity
– Urinary tract obstruction (stone)
• Mechanism
– G-ve facultative anaerobes e.g. E coli produce gas via
fermentation of glucose  high levels of nitrogen, oxygen, CO2
and H2 accumulating at inflammatory site  gas may extended
the inflammatory site to subcapsular, perinephric and pararenal
spaces
EPN histopathology
• Abscess formation
• Foci of micro and
macro-infarction
• Vascular thrombosis
• Numerous gas-filled
spaces
• Area of necrosis
surrounded by acute
and chronic
inflammatory cells
implying septic infarction
EPN presentation
• Age: 40-50
• S/s = pyelonephritis
– dysuria, fever/rigors, nause,
vomiting, flank pain
• Impaired consciousness
• Septic shock
• PE:
– Loin tenderness (most
common)
– Crepitus around renal area
or scrotum
• NOT respond to
pyelonephritis Tx
• Ix:
– Leucocytosis (70-80%
reported case)
– Thrombocytopenia (15-20%)
– Acute renal dysfunction
– Acid-base disturbance
– Hyperglycaemia
– Microscopic / gross
haematuria
– Severe proteinuria
EPN diagnosis
• Radiological Dx
– Gold standard: CT
• CT: more sensitive and
define extent of EPN by
identifying features of
parenchymal
destruction
• USG accuracy 69%,
KUB 65%
– KUB: abnormal gas
shadow in renal bed
EPN classification
• Base on CT feature
• Wan: used in 2 meta-analysis, prognostic value,
type 1 > 60% mortality, type2 > 20% mortality
• Huang and Tseng: for Mx
• One classification proposed by Wan et al
– Type I : parenchymal destruction with either an
absence of fluid collection or presence of streaky or
mottled gas (mortality 60%)
– Type II : renal or perinephric fluid collection with
bubbly or located gas or gas in the collecting system
(mortality 20%)
EPN prognostic factors
• Falagas et al J Uro
2007
• Poor PF:
1. SBP <90
2. Impaired consciousness
3. Increase serum Cr
4. Thrombocytopenia
5. Bil EPN
6. Medical Mx with Abx
alone
7. Wan’s Type I (air only, no
fluid)
• Factors NOT increased
mortality
– DM
– Stone
– E. coli
– K. pneumaiae
– Age >50
– Female
– Hx of UTI
– Alcoholism
EPN management
• High index of suspicion in pt fail medical treatment
for acute pyelonephritis
• Active resuscitation
• Medical Mx (MM)
– O2, IVF, Acid base balance, Abx, good glycaemic
control
– Keep SBP >100 with IVF +/- inotropes
– Empirical Abx: AG, b-lactamase inhibitor, CS,
quinolones, till c/st a/v
– Renal support if ARF
– ICU care if multiorgan support need
EPN Management
• Percutaneous drainage PCD + MM
– 1st
shown in Hudson et al. J Urol 1986
– Meta-analysis (Somani BK et al. J Urol 2008):
• PCD + MM as most successful Mx (30-100%) with lowest
mortality 13.5%, subsequent nephrectomy mortality 6.6%
– Significant reduction in mortality (nephrectomy mortality 40-50%)
– Preserve function of affected kidney in ~70% cases
– For pt with localized areas of gas + functioning renal tissue
– Multiple catheters for loculated/multiple abscess
– Tube can be flushed with Abx solutions
EPN: PCD + MM
• Huang and Tseng classification
– Class 1 (gas in collecting system only): PCD + MM
– Class 2 (parenchymal gas only): PCD +MM
– Class 3 (3A peripheric gas, 3B pararenal gas):
• Depend on risk factors:
– diabetes, thrombocytopenia, acute renal failure, altered
level of consciousness, shock
• 0-1 risk factor: PCD+MM survival rate 85%
• >=2 risk factors: failure 90%  nephrectomy
– Class 4 (soliatory kidney/Bil EPN):
• PCD + MM
– If failed to respond: Nephrectomy + ICU + renal support
Huang and
Tseng
classification
Class 1 Pelvicalyceal gas only
Class 2 Parenchymal gas only
Class 3A Perinephric gas
Class 3B Pararenal gas
Class 4 Solitary kidney/Bil
EPN
Risk factors:
1.DM
2.PLT
3.ARF
4.GCS
5.Shock
XanthogranulomatousXanthogranulomatous
pyelonephritispyelonephritis
Q68
• KUB and CT scan of a patient with vague
R flank pain and ballottable mass
• What is the diagnosis? (3)
• Under microscopy, what is a characteristic
feature in this condition? (2)
• KUB : multiple renal stones in R kidney
• CT : classic “bear’s paw” appearance,
lower cut showing stones inside dilated
calyces
• Dx : Right xanthogranulomatous
pyelonephritis (3)
• Lipid-laden macrophages (Xanthoma
cells) (2)
XanthogranulomatousXanthogranulomatous
PyelonephritisPyelonephritis
• Chronic renal infection that results in local or
diffuse (2 types) renal destruction.
• Almost all cases are unilateral
• A nonfunctioning, enlarged kidney associated with
obstructive uropathy secondary to nephrolithiasis
• Female in their 5th to 7th decade
• 75% have positive urine cultures and 90% have
positive tissue culture
• The commonest organisms isolated are Proteus or
E.coli
• 83% of patients have associated nephrolithiasis
• 50% such stones are of staghorn stones
Xanthogranulomatous PyelonephritisXanthogranulomatous Pyelonephritis
• Presentation: 70% flank pain, 70% fever/chills, 60% flank mass
• Histologically
– Accumulation of lipid-laden foamy macrophages (xanthoma
cells)
– Inflammatory process begins within the pelvis and calyces &
subsequently extends into and destroys renal parenchymal and
adjacent tissues.
– Can be confused with RCC even on frozen section
• Treatment :
– if malignancy suspected / kidney diffusely destroyed – open
nephrectomy
– very stuck and high risk of vessels and visceral injury
• Imaging triad (seen in 50-80%) :
– Unilateral renal enlargement
– no / poor function
– A large calculus in the renal pelvis
• Classic “Bear’s paw sign” on CT
Urinary TBUrinary TB
How to diagnosis urinary TB?How to diagnosis urinary TB?
• Presentation:
– Previous TB exposure
– Loss of appetite
– Fever, night sweat
– Loin pain , hematuria and suprapubic pain
• Physical examination:
– Temp , LN
– Chest , abdomen , genital (bead like cord)
• Bld , EMU, CXR, KUB, USG + RU
• EMU – more concentrated as TB is secreted
intermittently
1. Ziehl-Neelsen stain to look for acid fast bacilli
1. Bacterial smear is stained with carbol fuchsin for 2 minutes,
then decolorised with HCL and ethanol which then restained
with crystal violet  view under oil immersion
2. Acid-fast bacilli  pink, non acid fast bacilli  purple
3. Not suitable for gram stain as high lipid content of cell wall
2. Lowenstein-Jensen is an egg based solid culture medium
used to identify TB
3. Culture in a liquid medium takes 2-3 days whereas in a solid
medium takes 6-8 weeks
4. PCR to amplify the specific DNA by in-vitro enzymatic
replication
• Pathogensis – caseating granuloma (Langhan’s giant cells
surrounded by lymphocytes and fibroblast)  fibrosis +
calcification  autonephrectomy
• TB epididymis is likely from hematogenous spread as it is usually
isolated finding
How to diagnosis urinary TB?How to diagnosis urinary TB?
• Tuberculin: purified protein deverivative to prove TB status.
– Positive  confirmed exposure to TB
– Negative  exclude the diagnosis
• CXR: lung primary focus in 50% of cases with urogenital TB
• KUB shows calcification in 50% of cases
• CT or IVU is abnormal in 60-90% of cases
1. Small shrunken kidneys (autonephrectomy)
2. Infundibular stricture (pathognomonic)
3. Calyceal distortion + calcification
4. Papillary necorisis
5. Multiple ureteric stricture : commonly at lower third of ureter
6. Distortion of ureteric orifice – VUR (Golf-Hole app)
7. Contracted calcified bladder: Bullous edema , ulcearation and
hemorrhage (Thimble bladder)
8. Calcified vas (beaded), seminal vesicle or prostate
What is the treatment of TB?
• Isoniazid, rifampicin, ethambutol and
pyrazinamide for 2 months
• Isoniazid and rifampicin for 4 months
• Steroid for ureteric stricture that do not respond
to anti-TB drugs
• Cycloserine is used to inhibit the growth of BCG
sepsis within 24 hours
– But if will lower seizure threshoid
What is the complication of
the drugs?
ProstatitisProstatitis
Acute bacterial prostatitis
• Infection of the prostate asso with LUT infection & generalized
sepsis
• Risk factor:
– UTI
– Acute epididymitis
– Catheter , post TURP
– Intraprostatic ductal relfux
– Phimosis
– Prostate stone
• Presentation:
– Systemic illness
– Preineal and SP pain
– Irritative LUTS
– AROU
– Prostate is exteremely tender
• Investigation:
– Bld + c/st
– MSU
• Txn:
– Antibiotic: Cirpo 500mg BD for 2-4 week
– Pain relief
– Catheter
– Prostate abscess: dx by TRUS or CT
– Drainage: percutaneous or TUR
Men present with recurrent UTI
• History:
– Associate LUTS
– Stone disease
– Diverticulum +/- fistula: pneumaturia, recurrent diarrhoea ,
rectal bleeding , fecaluria
– Chronic prostatitis : Dysuria, hematuria, Perineal/suprapubic
discomfort, Ejaculatory problems
• PE:
– Abd + kidney
– Suprapubic region
– External genitalia and prostate
• Investigation:
– MSU
– KUB
– USG
– FR + RU
– Specific test : Stemey + NIH-CPSI
UTI in men
• Men should receive, as minimum therapy,
a 7-day antibiotic regimen
• Minimum treatment duration of 2 weeks is
recommended, preferably with a
fluoroquinolone if prostatic involvement
• Prophylactic antibiotics reduce the risk of
bacteriuria and septicemia by 70% and
80% respectively after TURP
– Berry: Prophylactic antibiotics in TURP J Urol
2002
Prostatitis
• Definition: Infection or inflammation of prostate
• Chronic prostatitis:
– Clinical syndrome characterize by pain in perineum, pelvis, suprapubic
area or external genitalia
– Variable degree of voiding or ejaculatory disturbance
• Dx of exclusion : to rule out BPH , stricture, UTI
• Pathophysiology poorly understood:
1. Infection
2. Chemical irritation
3. Dysfunctional high-pressure voiding
4. Intraductal reflux
5. Altered immunity
– Proposed inflammatory process cause tissue edema &
intraprostatic pressure  local hypoxia  mediator
induced tissue damage altered neurotransmission in
sensory nerve  pain and other symptom
What is the definition ofWhat is the definition of
prostatitis?prostatitis?
>10 WBC /HPF
Prostadynia – pain without positive culture or inflammatory component
What is stamey test?What is stamey test?
Meares and Stamey
• Drink 400ml of water 30min before the test
• 4 sterile specimen container: VB1, VB2, EPS, VB3
• Expose glans penis and retract foreskin
• Cleanse the glans with soap
• 1st
10-15ml urine: VB1
• Pass next 100-200ml into toliet
• 2nd
10-15ml urine: VB2
• Patient bend forward & hold container marked EPS near
urethral meatus
• Massage prostate until few drops of prostatic secretion
are collected : EPS
• Void and collect the 10-15ml urine: VB3
Interpretation of Stamey test
• +ve VB1: Urethritis
• +ve VB2: Cystitis
• Chronic prostatitis
– II: +ve c/st in EPS & VB3
– IIIa: -ve c/st in EPS & VB3, +ve WBC
– IIIb : -ve c/st in EPS & VB3 , -ve WBC
• Modification of Stamey test:
– Pre & post-message test (PPMT) [Nickel]
– +ve post-message c/st  chronic prostatitis
ProstatitisProstatitis
• NIH – CPSI (National Institutes of Health- Chronic Prostatitis
Sympotm Index)
– Measure the severity of chronic prostatitis
– 9 item questionnaire with 3 main domains (pain, urinary symptoms and
QOL)
– Pain (location, frequency , severity)
– Voiding (obstructive and irritative)
– QOL
– For assess need of treatment and monitor response
• MTOPS study suggests that prostatitis may be a predictor of BPH
progression
• Nickel and coworker report a 2% incidence of bladder CIS in
patients with clinical prostatitis and they therefore recommend urine
cytology when investigating men with suspected prostatitis
Management
• According to predominant symptom & QOL
• Discuss about benign nature of the condition
• Lock of evidence in favour of any treatment
• Goal should be symptom control rather than
eradication
• Conner stone:
– Antibiotic
– Anti-inflammatory
– Alpha-blockers
Chronic bacterial prostatitis RxChronic bacterial prostatitis Rx
• NSAID/Antibiotics at least 6 weeks - empirical treatment
suggested by European consensus group
• E Coli positive in prostate massage in asymptomatic patient
should be treated
• Quinolone and tetracycline – good penetration
• Moxifoxacin – good in G+ve
• Macrolide – good for chlamydia
• Tetracyclin for sub-clinical infection : Chlamydia & ureaplasma
• Nitrofurantoin and penicillin – poor penetration
• Add alpha blocker for 3m if no response by 6week
• Finasteride can cause a 50% improvement in the symptoms
of about 50% of patients with type 3 prostititis
• Muscle relaxant – diazepam or baclofen
• Tricyclic antidepressant: Amitriptyline
• Prostatic message if not responsive
– Expression of prostatic secretion, relief of pelvic muscle spasm,
physical disruption of protective biofilm and improve circulation
– Some symptomatic relief in ~1/4 to 1/3 patients
Epididymitis & Orchitis
Scrotal pain and fever
• Ddx: Trauma , testicular torsion , epididymo-orchitis
• History
– Trauma
– < 35 yo STD: Chlamydial or gonococcal
– In old: UTI cause by E coli
– UTI : dysuria, frequency , urgency , SP pain
– Systemic illness
– Long term use of amiodarone (chemical epididymitis)
• P/E:
– Cannot diff from torsion
– Scrotal pain radiate to groin
– Erythema or scrotal skin
– Thickening of spermatic cord, reactive hydrocele
– Urethral discharge
– Elevation of scrotum relieved pain in epididymo-orchitis (Prehn’s
sign)
• Investigation:
– MSU
– Gram staining and C/st of urethral swab (Gram –ve intracellular
diplococci)
– Chlamydia: detect DNA by PCR on first void urine
– Basic blood test
• Treatment:
– Bed rest, scrotal suppor
– Analgesic
– Antibiotic: Cipro 500mg BD (cover gonococccal) + Doxycycline
100mg BD (cover Chlamydia) x 2 weeks
– If allergic to doxycycline  azithromycin 1g x1
– If elderly  likely E coli : Ciprofloxacin only
– Order USG if not resolved (abscess)
– FR + RU exclude underlying LUTS
• Complication:
– Abscess, infarction , chronic pain , infertility
• Mumps orchitis: 30% post-pubertal male, 3 day after
parotitis, 30% bilateral , result in testicular atrophy and
infertility
BiofilmBiofilm
What is the biofilm?What is the biofilm?
• Complex aggregation of organisms on
solid substrate, protected by extracellular
mucopolysaccharide matrix in an aqueous
environment
• Or , structured community of micro-
organisms and their extracellular products
form on the surface of any biomaterial
UTI in pregnancyUTI in pregnancy
Anatomic & Physiologic
Changes
• 1cm increase in renal length
• Smooth muscle atony of collecting system
– Progesterone & Uterus size
• Bladder displaced superior & anterior
• 30-50% increase in GFR
– Evaluate renal Fx if Cr >0.8 or BUN >13
– Normal to have proteinuria up to 300mg/24
hours
UTI
• Incidence of male UTI - 1%
• Incidence of female UTI – 5%
• Incidence of female UTI after
menopause – 20%
• High fluid intake/voiding every 4 hrs/
post-coital voiding/perineal hygiene
• -ve urine c/st to confirm eradication of
bacteria
Asymptomatic Bacteriauria
• All women should be screen at week16
• Definition:
– Asymptomatic + 10 5
(CFU) of a single pathogen / ml of urine
– But 102
CFU can also be counted as significant
• Asymptomatic bacteriuria in pregnancy – ~5%
• Risk of acute pyelonephritis: in 3rd
trimester
– 1-4% in all pregnant women
– 20-40% in untreated bacteriuria
• Treatment is necessary  1% if treated
• 3-day course of therapy
• Reculture urine 1-2 days after treatment
• Use parenteral agents to treat acute pyelonephritis
Antibiotics
Safe:
• Penicillin: OK
• Cephalosporin: OK
• Marcolide - Erythromycin (bacteriostatic): OK
Use with cautions:
• Nitrofurantoin: avoid in third trimester
– Fetal hemolytic anemia in G6PD deficiency mother
– hepatotoxicity, lung toxicity, inadequate urine concentration if GFR<60
• Aminoglycoside (bacteriostatic): CI in 2nd
and 3rd
trimesters
– can cross placental barrier: fetal ototoxicity & nephrotoxicity
– Used only for short periods for severe acute pyelonephritis threatening
materal-fetal prognosis
• Sulphonamide : contraindicated in third trimester
– Risk of neual tube defect in 1st
trimester due to anti-folate mechanism
– Risk of fetal anemia in G6PD def mother
• Triamethoprim : contraindicated in first trimester
Contraindicated:
• Fluoroquinolone (bacteriostatic):
contraindicated as toxicity to fetal cartilage and
joints, tendon damage
• Chloramphenicol: contraindicated in third
trimester as “grey-baby” syndrome
• Tetracycline (bacteriostatic): contraindicated
as hepatotoxicity, deposit in teeth and bone
• Recurrent UTI in pregnancy – cephalexin 125mg
daily
Acute pyelonephritis
• USG findings: focal or diffuse hyperechogenicity,
thickening of renal pelvis and ureteral dilation
• Higher risk if asymptomatic bacteriuria / VUR
(correction of VUR cannot prevent UTI during
pregnandy) / history of renal scarring
• Complications associated with bacteria during
pregnancy
– Prematurity, low birth weight, prenatal mortality
– Maternal anemia
• Hospitalization and parental antibiotics
Pregnancy and VUR
• Higher chance of pyelonephritis if previous VUR or
history of renal scarring
• History of renal scarring
– Higher chance of HT (3.3 fold)
– Pre-eclampsia (7.6 fold)
– Obstetric intervention
• Higher chance of pre-eclampsia if bilateral scarring
or impaired creatinine level
• Despite previous reimplantation in childhood, still
higher risk of UTI, but not miscarrage
(Spontaneous renal rupture)
• No cause vs upper tract obstruction vs
tumour like AML
• Lumbar or abdominal pain / shock
• US : retroperitoneal hematoma
• JJ / PCN if obstruction
• Unstable hemodynamically: nephrectomy
Before having babies…
• Consider stone treatment before
pregnancy
• Consider AML treatment
GentamicinGentamicin
How to use gentamicin?
• Bactericidal – inhibit ribosomal protein synthesis
• 3-7mg/Kg
• Check level after the 3rd dose
• <1mg/l  give the same dose
• 1-2mg/l  reduce the dose by 25% and check the level before
next dose
• 2mg/l  omit one dose and check the level
• Bad with Frusemide (increase nehrotoxicity)
• Good for pseudomonas, enterococcus and staphylococcus
• Daily dose is usually used
• Can be used in patient with renal impairment with dose modification
• Ototoxicity cause more commonly vestibular damage than
deafness, 2/3 patients present as tinnitus
• Nephrotoxicity and impaired neuromuscular transmission
UTI in renalUTI in renal
impairmentimpairment
What is the antibiotic in renal
impairment?
Catheter related UTICatheter related UTI
• Up to 25% of hospitalized patients undergo urinary catheterization.
• indwelling urinary catheters are a leading cause of nosocomial
infection and have been associated with both morbidity and
mortality.
• Up to 30% of catheterized patients can have genitourinary or
systemic symptoms related to catheter-associated UTI (CAUTI)
• Up to 4% may develop catheter-related bacteraemia
• Once the catheter has been removed some patients with
asymptomatic CAUTI continue to have bacteriuria or become
symptomatic
• To prevent or reduce this type of catheter-related morbidity, many
clinicians have a policy of administering a short course of
prophylactic antibiotics on catheter withdrawal for all or selected
groups of patients.
• Currently, the most appropriate agents for the empirical
management of CAUTIs seem to be co-amoxiclav, ciprofloxacin and
nitrofurantoin.
What is the recommendation of
catheter insertion and choice of
catheter?
How to prevent catheter
related UTI?
What is the treatment of
catheter related UTI?
Patient with dysuria,
KUB
SPINAL CORD INJURY & UTI
Spinal cord injury patients
• 33% have bacteriuria
• UTI is the most common urologic complication &
the most common cause of fever in these
patients
• Risk factors:
– Bladder overdistention
– Elevated intravesical pressure
– VUR
– Impaired voiding
– Instrumentation
Clinical presentation &
Bacteriology
• Majority are asymptomatic
• Symptoms:
– Abdominal discomfort
– Urinary leakage
– Lethargy / Malaise
– Cloudy, malodorous urine
• E. coli isolated in only ~20%
• Enterococci, P. mirabilis, Pseudomonas
Management
• SP cath delay onset of bacteriuria, when
compared with indwelling urethral cath
• CIC allows for lowest risk of complications
• Urine culture prior to therapy
• Oral fluoroquinolone is 1st
line
Emphysematous cystitis
• Necklace appearance of gas beads in
bladder wall diagnostic of emphysematous
cystitis
• due to infection by gas forming organisms
(commonest E Coli) in an
immunocompromised patient (usually DM)
Emphysematous Cystitis
EC
• DDx:
– Instrumentation
– Fistula to hollow viscus
– Tissue infarct with necrosis
– Infection
• EC more common in
– Middle aged diabetic women
(M: F = 1:6)
• Predisposing factors
– DM (66%), Chronic UTI,
indwelling urethral catheter,
urinary stasis due to BOO,
neurogenic bladder
• Various s/s
– Asymptomatic, pneumaturia,
irritative voiding, acute
abdomen to severe sepsis
• Pathogens:
– E. coli (58%)
– Others: K. pneumoniae, P.
aeruginosa, Proteus mirabilis,
Candida albicans and C.
tropicalis, Aspergillus fumigatus,
Staphylococcus aureus, Group D
Streptococcus, Enterococcus
faecalis, Enterobacter aerogenes
and Clostridium perfringens and
Cl. welchii.
• Pathogenesis:
– like EPN,
– non-diabietic: urinary albumin as
substrate
EC
• Radiological Dx
– KUB: curvilinear area of
radiolucency delineating
the bladder wall with or
without intraluminal air
– CT: more sensitive, define
extent and severity,
differentiate vesicoenteric
fistula, intraabdominal
abscess, adjacent
neoplastic disease, EPN
• Histopathology
– Gross:
• Bladder wall thickening
with vesicles of varying
size
– Microscopic:
• multiple gas-filled
vesicles predominantly
within the bladder
mucosa, lined by
flattened fibrocytes and
multinucleated giant
cells
EC management
• MM:
– Abx, bladder drainage, DM control, correct
underlying comorbidities
• If fail to respond/severe necrotizing
infection (10%)
– Consider partial cystectomy, cystectomy or
surgical debridement
– EC alone Mortality 7%
– EC + EPN Mortality 14%
EndotoxinEndotoxin
What is endotoxin?What is endotoxin?
• Lipopolysaccharide complex related to the outer
membrane of gram negative bacteria
• Gram negative sepsis
• Their lipid component is the toxic one (Lipid A)
and the polysaccharide element is the
immunogenic one (O-antigen)
• Endotoxins are heat stable to boiling point
Papillary necrosisPapillary necrosis
What is papillary necrosis?What is papillary necrosis?
• Possible causes of papillary necrosis is
POSTCARD
• Pyelonephritis, Obstruction. Sickle cell,
Tuberculosis, Cirrhosis, Analgesic, Renal
vein thrombosis, Diabetes
HIV in urology
Viral disease of the genital
tract
 Painful ulcer
 Diagnosis? (1) Chancroid
 Causative agent? (1) Haemophilus ducreyi
Q3
ChancroidChancroid
• Presentation: painful nonindurated ulcer + tender unilateral
inguinal adenopathy
• Characteristic suppurative inguinal adenopathy
• Haemophilus ducreyi :
– fastidious (difficult to culture)
– short, fine, gram-negative streptobacilli
– FDA approved: PCR assays
• Treatment:
– Ciprofloxacin, (500 mg orally BD for 3 days)
– Erythromycin , (500 mg orally TID for 7 days)
– Azithromycin, (1 g as a single oral dose )
– Ceftriaxone, (250 mg as a single intramuscular dose )
– Tetracycline
Male 30 with painless ulcer over coronal
sulcus
Genital
• What is the diagnosis?
– Chancre, ulcer typically painless, indurated and with
raised border. Regional lymphadenopathy appear in
one week.
• What is the causative agent?
– Treponema pallidum (spirochetes), confirmed by dark
field examination
• What is the treatment?
– Penicillin – good prognosis if treated. If not treated >
neurosyphillis/dementia/gumma
Male 25 with lesion over glans. Biopsy done.
Genital
• What is the diagnosis?
– Condyloma acuminatum
• What is the causative agent?
– Human papillomavirus types 6,11.
– Dysplastic types are caused by type 16, 18.
(premalignant)
• What is the treatment?
– Podophyllin, cautery after biopsy or surgical excision
or CO2 laser
Condyloma
acuminatum of
scrotum
25 year old man with ulcer over glans.
Genital
• What is the diagnosis?
– Granuloma inguinale - Irregular painful ulcer with
purulent base. No inguinal lymphadenopathy, but
subcutaneous granulomatous process
– Dx: identification of “Donovan Body” on stained
smear
• What is the cause?
– Calymmatobacterium granulomatis
• What is the treatment?
– Tetracycline/ampicillin , septrin or erythromycin
25 year old man with painful lesions
over penile skin
Genital
• What is the diagnosis?
– Genital herpes.
• What is the cause?
– Usually herpes simplex virus type 2 infection
• What is the treatment?
– Acyclovir, long term suppression may be
required if recurrence. Prevent transmission
with barrier contraception
Male 25, itchy lesion over penile
skin. Biopsy done
Genital
• What is the diagnosis?
– Molluscum contagiosum – small papules, may
express cheesy-like material
• What are the diagnostic features on histology
exam?
– Molluscum bodies in cells (Basophilic inclusion filled
with the virus) in biopsy
• What is the cause?
– Viral infection by poxvirus, transmitted by sexual
contact
• What is the treatment?
– Self limited. Healed without scars. Podophyllin or
cauterisation
Schistosomiasis
Schitosomiasis (Biharzia)
• Cause: trematode called Schitosoma
haematobium
• Endemic : Africa , Egypt, middle east
• Pathology :
– Fresh water snails release infective form of the
parasite (cercariae)
– Penetrate skin and migrate to live (schitosomules)
where they mature
– Adult form migrate to vesical vein
– Lay egg (containing miracidian larvae)  leave body
by pentrating the bladder and enter urine
• 2 phase:
– Active: where adult worm laying eggs
– Inactive: when adult die and reaction to remaining egg
• Clinical presentation:
1. “Swimmer’s itch” : local inflammation by cercarial penetration
(24hr)
2. Katayama fever (acute schistosomiasis):
• Egg lying : induce fever, urticaria, LN, Hepatosplenomegaly
3. Acute inflammation phase: egg penetrate & excreted in urine :
hematuria, frequency and terminal dysuria
4. Chronic active phase:
• Low egg laying
• Nephritic syndrome by deposition of IG complex in glomeruli
5. Chronic inactive phase: no viable egg
• Symptom of obstructive uropathy
Diagnosis + MxDiagnosis + Mx
Diagnosis:
1. Midday urine: continue egg
2. Bladder and rectal biopsy : identify egg
3. Serology test: ELISA
4. Cystoscopy: identifies egg in trigone (Sandy Patches)
5. CT or IVU: calcified , contracted bladder with obstrucitve uropathy
6. USS: hydronephrosis and thicken bladder wall
Treatment is pharmacological with praziquental
• 20 mg/kg in 2 divided does 4-6 hours apart on the same day
• Single dose of praziquental may be effective
• Praziquental is effective against all species of schistosoma and all
stages of the disease. It will cure 85-100% of cases. When it fails to
cure the disease a second course of praziquental could be tried
• Complications - Bladder contracture, ureteric obstruction, squamous
cell ca bladder
These are the eggs of 3 species of Schistosoma
 Which of the above species is related to bladder cancer?
(1)
 In what form does this species infect human in water? (1)
A B C
• A : Schistosoma japonicum
• B : Schistosoma haematobium
• C : Schistosoma mansoni
• B (1)
• Cercariae (1)
– The flatworm cercaria is found in river water and will penetrate
unbroken human skin, typically through the web between toes,
to enter the peripheral systemic vein
– The eggs will penetrate through the bladder wall and will be
found in the urine
Urinary schistosomiasisUrinary schistosomiasis
• Urinary schistosomiasis is most commonly
caused by schistosoma hematobium. This
is endemic in Africa and middle east. It
produces the characteristic end spined
eggs but this is not the only species with
end spined eggs
• Schistosoma japonicum is endemic in the
far east
• Schistosoma Mansoni in Latin America
 What is the diagnosis? (1)
 What is the acute phase of this disease called? (2)
• Characteristic egg-shell calcification outlining urinary
bladder
• Dx : Schistosomiasis (1), DDX: TB
• Katayama fever (2)
– Coincides with egg laying
– Active phase is characterized by urinary symptoms such as
hematuria and terminal dysuria. Cystoscopically there may be
inflammatory polypoid lesions in the bladder and eggs in the
urine
– The chronic inactive phase,although asymptomatic, will slowly
progress into obstructive uropathy and may be complicated by
bladder cancer
Hydatid diseaseHydatid disease
Hydatid diseaseHydatid disease
• Also known as echinococcus, is a tapeworm parasite infection
• The intermediate host is the sheep and the final host is the dog.
• Kidneys can be affected in about 5% of cases
• The disease is bilateral in 6% of cases
• In the kidney the upper and lower poles of the kidneys are more
commonly affected (80%) than the midpole of the kidney
• The renal cysts are not symptomatic until late in the disease
• Common symptoms are flank pain (80%) and flank mass (40-75%)
• USG and CT scans show thick wall multiloculated cysts
• KUB shows calcifications in 30% of cases
• Bld: peripheral eosinophilia & +ve hydatid complement fixation test
• Medical: Albendazole
• The mainstay of treatment is surgical excision of he cysts with 1st
sterilized with formalin or alcohol
• Diagnosis ? (1)
Q11
• Angiokeratoma of Fordyce (1)
• No malignant potential (1)
Angiokeratoma of Fordyce
• Vascular ectasias of dermal blood vessels
• Visible on the penis and scrotum of adult men
• 1- to 2-mm red or purple papules with associated
generalized scrotal redness
• Benign condition without systemic manifestations
• Rare cause of troublesome scrotal bleeding Can
be seen in patients with Fabry's disease : rare
glycogen storage deficiency
• Treatment :
– Usually unnecessary
– Success achieved using YAG, KTP/ argon laser
photocoagulation in select cases
Physical findings of a sexually inactive 20-yr-old male
 Diagnosis ? (2)
 Is it associated with HPV infection? (1)
• Pearly penile papules (PPP) (2)
• No relationship with HPV. Benign lesion
(1)
PPP
• White, dome-shaped, closely spaced small
papules at glans penis
• Arranged circumferentially at corona
• Histology : angiofibromas similar to lesion TS
• 14-48% of young adults (uncircumcised)
• NO association with HPV infection/ cervical CIN
• Mx: Reassurance
• Local destruction: CO2 laser, cryotherapy
 These ulcers in a sexually-inactive 20-yr-old man
are painful and recurrent.
 Diagnosis ? (3)
Q29
• Pictures showing multiple scrotal, perianal
ulcers as well as oral aphthous ulcers
• Behçet’s disease (3)
Behçet’s disease
• Classified as a form of vasculitis
• Initially found along Silk Road, now found everywhere in the world
• No gender difference in epidemiology, mean age of onset ~30yrs
• Clinical manifestation:
– Mucous membrane manifestation
• Oral aphthosis (nearly in every patient)
• Genital aphthosis (60-100% of patients) : Scrotal and vulval ulceration,
sometimes on shafts of penis
– Skin manifestation
• Skin aphthosis / pustulosis
• Pathergy phenomenon (skin hypersensitivity to trauma, considered a
diagnostic test)
– Ocular manifestation
• Anterior and posterior uveitis, retinal vasculitis
– Arthritis, Meningoencephalitis, Vascular involvement (DVT), gastrointestinal
aphthosis
• Diagnostic criteria: International Criteria for Behçet’s disease (ICBD)
• Genetic background: HLA-B51 may be associated
• Treatment: Colchicine 1mg daily is 1st
line
 This is the result of a chronic infective process
 Name three possible micro-organisms responsible. (3)
 Name one vector of transmission of the above micro-
organisms (1)
Q30
• Picture showing penoscrotal elephantiasis
1. Wucheraria Bancrofti (1)
2. Brugia Malayi (1)
3. Onchocerca volvulus (1)
4. Vectors
• (W. bancrofit, B. malayi) Mosquito eg. Culex spp
• (O. volvulus) Black fly of Simulium spp
• Dx: Thick film , serology or biopsy
• Presentation:
– Funiculoepididymitits, orchititis
– Hydrocele
– Scroal and penile elephantitis
• Treatment:
– Medical: Diethylcarbamazine
– Surgerical excision of fibrotic & edematous tissue
This is an STD
 What is the diagnosis? (1)
 What is the causative organism? (1)
 Name two other diseases this organism is
responsible for (0.5 each)
Q47
• Lymphogranuloma venereum (LGV) (1)
• Chlamydia trachomatis (serotype L1, L2,
L3) (1)
1. Trachoma (serotype A, B, Ba, C) (0.5)
2. Non-gonococcal urethritis (serotype D to K)
(0.5)
Lymphogranuloma VenereumLymphogranuloma Venereum
• STD caused by Chlamydia trachomatis types L1, L2 & L3
• Transient painless ulcer on the penis, anus or vulvovaginal area that
goes unnoticed  painful unilateral suppurative inguinal adenopathy
and constitutional symptoms that occur 2-6wks after resolution of the
ulcer
• Groove sign: large inguinal and femoral LN separated by inguinal
ligament. Secondary LN lesions in lymphogranuloma venereum
• Mainly clinical diagnosis
• Culture positive <50% cases
• Can be diagnosed using antibody titre
• Tx: Doxycycline 100mg BD or erythromycin 500mg QID for three weeks
at least
Photo
• This elderly woman complained of severe
symptoms of cystitis of sudden onset.
Q
• A. What abnormality is shown?
– herpes zoster (1/2)
• B. What are the typical cystoscopic
appearances?
– hemitrigonal vesicles (1/2)
Q. CT
• These are CT and ultrasound scans of a
74 year old man with urinary retention and
fever of 38.6
Q
• A. What is the diagnosis?
– prostatic abscess (1)
• B. How should his retention be managed?
– suprapubic catheterisation and drainage of
abscess (1)
Antibiotic prophylaxis in urology
• Brief course of antibiotic administer before
or at the start of an intervention
• To minimize the infectious complications
of the procedure
• Possible side effect & microbial resistance
patterns are potential risk
• Yes with high level of evidence:
– TURP (decrease bacteriuria & infectious complication)
– Prostate biopsy (reduce bacteriuria but no conclusive evidence
on reducing symptomatic UTI or other infectious complication)
• Yes with moderate to low evidence:
– Cystoscopy (not require in the absence of risk factor)
– Therapeutic URS
– Open /lap uro intervention (clean-contaminated & contaminated)
• Not required in:
– Urodynamic study (except with increase risk e.g neurogenic
bladder, transplant patient, immunocompromised , VUR)
– TURBT
– ESWL (in uncomplicated case & pre-op –ve c/st)
– URS (diagnostic)
– PCNL (when pre-op –ve c/st)
– Open /lap uro intervention (clear surgery)

More Related Content

What's hot

bladder pain syndrome / interstitial cystitis
bladder pain syndrome / interstitial cystitisbladder pain syndrome / interstitial cystitis
bladder pain syndrome / interstitial cystitis
Dr Mayank Mohan Agarwal
 
Bladder neck reconstruction
Bladder neck reconstructionBladder neck reconstruction
Bladder neck reconstruction
Sunil Kumar
 
Pfudd classification
Pfudd  classificationPfudd  classification
Pfudd classification
GovtRoyapettahHospit
 
Open Retropubic Prostatectomy
Open Retropubic Prostatectomy Open Retropubic Prostatectomy
Open Retropubic Prostatectomy
shankaruro84
 
Stress urinary incontinence dr. kawita bapat
Stress urinary incontinence dr. kawita bapatStress urinary incontinence dr. kawita bapat
Stress urinary incontinence dr. kawita bapat
Kawita Bapat
 
Artificial urinary sphincter - Operative
Artificial urinary sphincter - OperativeArtificial urinary sphincter - Operative
Artificial urinary sphincter - Operative
AbhishekPandey1012
 
Tips and tricks semirigid urs final
Tips and tricks semirigid urs finalTips and tricks semirigid urs final
Tips and tricks semirigid urs final
Ahmed Eliwa
 
Prostatitis-ppt (1).pptx
Prostatitis-ppt (1).pptxProstatitis-ppt (1).pptx
Prostatitis-ppt (1).pptx
ShaliniN51
 
Bladder carcinoma- augmentation cystoplasty complications
Bladder  carcinoma- augmentation cystoplasty complicationsBladder  carcinoma- augmentation cystoplasty complications
Bladder carcinoma- augmentation cystoplasty complications
GovtRoyapettahHospit
 
BPH- Pathology & Investigations
BPH- Pathology & InvestigationsBPH- Pathology & Investigations
BPH- Pathology & Investigations
Ankur Agarwal
 
Undescended testicle
Undescended testicleUndescended testicle
Undescended testicle
fikri asyura
 
Lower Urinary Tract Symptoms(LUTS).pptx
Lower Urinary Tract Symptoms(LUTS).pptxLower Urinary Tract Symptoms(LUTS).pptx
Lower Urinary Tract Symptoms(LUTS).pptx
DrMohaiminurRahmanMS
 
Surgical management of urethral stricture
Surgical management of urethral strictureSurgical management of urethral stricture
Surgical management of urethral stricture
miraage
 
Orthotopic neobladder
Orthotopic neobladderOrthotopic neobladder
Orthotopic neobladder
Prateek Laddha
 
URODYNAMICS
URODYNAMICSURODYNAMICS
Complications of penile prostheses
Complications of penile prosthesesComplications of penile prostheses
Complications of penile prostheses
Aswan University | جامعة أسوان
 
Penis priapism
Penis  priapismPenis  priapism
Penis priapism
GovtRoyapettahHospit
 
Bladder diverticulum
Bladder diverticulumBladder diverticulum
Bladder diverticulum
AbhishekPandey1012
 
Urogynacology fistulae overview
Urogynacology  fistulae overviewUrogynacology  fistulae overview
Urogynacology fistulae overview
GovtRoyapettahHospit
 

What's hot (20)

Pfudd
PfuddPfudd
Pfudd
 
bladder pain syndrome / interstitial cystitis
bladder pain syndrome / interstitial cystitisbladder pain syndrome / interstitial cystitis
bladder pain syndrome / interstitial cystitis
 
Bladder neck reconstruction
Bladder neck reconstructionBladder neck reconstruction
Bladder neck reconstruction
 
Pfudd classification
Pfudd  classificationPfudd  classification
Pfudd classification
 
Open Retropubic Prostatectomy
Open Retropubic Prostatectomy Open Retropubic Prostatectomy
Open Retropubic Prostatectomy
 
Stress urinary incontinence dr. kawita bapat
Stress urinary incontinence dr. kawita bapatStress urinary incontinence dr. kawita bapat
Stress urinary incontinence dr. kawita bapat
 
Artificial urinary sphincter - Operative
Artificial urinary sphincter - OperativeArtificial urinary sphincter - Operative
Artificial urinary sphincter - Operative
 
Tips and tricks semirigid urs final
Tips and tricks semirigid urs finalTips and tricks semirigid urs final
Tips and tricks semirigid urs final
 
Prostatitis-ppt (1).pptx
Prostatitis-ppt (1).pptxProstatitis-ppt (1).pptx
Prostatitis-ppt (1).pptx
 
Bladder carcinoma- augmentation cystoplasty complications
Bladder  carcinoma- augmentation cystoplasty complicationsBladder  carcinoma- augmentation cystoplasty complications
Bladder carcinoma- augmentation cystoplasty complications
 
BPH- Pathology & Investigations
BPH- Pathology & InvestigationsBPH- Pathology & Investigations
BPH- Pathology & Investigations
 
Undescended testicle
Undescended testicleUndescended testicle
Undescended testicle
 
Lower Urinary Tract Symptoms(LUTS).pptx
Lower Urinary Tract Symptoms(LUTS).pptxLower Urinary Tract Symptoms(LUTS).pptx
Lower Urinary Tract Symptoms(LUTS).pptx
 
Surgical management of urethral stricture
Surgical management of urethral strictureSurgical management of urethral stricture
Surgical management of urethral stricture
 
Orthotopic neobladder
Orthotopic neobladderOrthotopic neobladder
Orthotopic neobladder
 
URODYNAMICS
URODYNAMICSURODYNAMICS
URODYNAMICS
 
Complications of penile prostheses
Complications of penile prosthesesComplications of penile prostheses
Complications of penile prostheses
 
Penis priapism
Penis  priapismPenis  priapism
Penis priapism
 
Bladder diverticulum
Bladder diverticulumBladder diverticulum
Bladder diverticulum
 
Urogynacology fistulae overview
Urogynacology  fistulae overviewUrogynacology  fistulae overview
Urogynacology fistulae overview
 

Viewers also liked

Paediatric Urology [Dr.Edmond Wong]
Paediatric Urology [Dr.Edmond Wong]Paediatric Urology [Dr.Edmond Wong]
Paediatric Urology [Dr.Edmond Wong]
Edmond Wong
 
Hypospadias part 1 introd (step by step oper series)
Hypospadias part 1 introd   (step by step oper series) Hypospadias part 1 introd   (step by step oper series)
Hypospadias part 1 introd (step by step oper series)
Mohammed Abd El Wadood
 
Human Renal Transplantation [Dr. Edmond Wong]
Human Renal Transplantation [Dr. Edmond Wong]Human Renal Transplantation [Dr. Edmond Wong]
Human Renal Transplantation [Dr. Edmond Wong]
Edmond Wong
 
urinary tract infection
urinary tract infection urinary tract infection
urinary tract infection
kasinghshekhawat
 
SBAR Paper on Urosepsis and Dehydration
SBAR Paper on Urosepsis and DehydrationSBAR Paper on Urosepsis and Dehydration
SBAR Paper on Urosepsis and DehydrationMichelle King
 
Hypospadias 2 orthoplasty & ttt options step by step oper series
Hypospadias 2 orthoplasty & ttt options   step by step oper series Hypospadias 2 orthoplasty & ttt options   step by step oper series
Hypospadias 2 orthoplasty & ttt options step by step oper series
Mohammed Abd El Wadood
 
Uti
UtiUti
Uti -for_non-urologists-uncomplicated and complicated
Uti  -for_non-urologists-uncomplicated and complicatedUti  -for_non-urologists-uncomplicated and complicated
Uti -for_non-urologists-uncomplicated and complicatedmaiim
 
Uti and lab diagnosis
Uti and lab diagnosisUti and lab diagnosis
Uti and lab diagnosis
gargitignath12
 
S ameer 2015 dysuria
S ameer 2015    dysuriaS ameer 2015    dysuria
S ameer 2015 dysuria
mt53y8
 
Hypospadias 3: MAGPI & snod grass (TIP) step by step operative urology series
Hypospadias 3: MAGPI & snod grass (TIP)   step by step operative urology series Hypospadias 3: MAGPI & snod grass (TIP)   step by step operative urology series
Hypospadias 3: MAGPI & snod grass (TIP) step by step operative urology series
Mohammed Abd El Wadood
 
Pyelonephritis csbrp
Pyelonephritis csbrpPyelonephritis csbrp
Pyelonephritis csbrp
Prasad CSBR
 
URINARY SYSTEM DISORDERS of ROBB, FILAMER
URINARY SYSTEM DISORDERS of ROBB, FILAMERURINARY SYSTEM DISORDERS of ROBB, FILAMER
URINARY SYSTEM DISORDERS of ROBB, FILAMER
shenell delfin
 
Urine Interpretation / Test / Analysis
Urine Interpretation / Test / AnalysisUrine Interpretation / Test / Analysis
Urine Interpretation / Test / Analysis
Dr Anshul Varshney
 
Chronic pyelonephritis
Chronic pyelonephritisChronic pyelonephritis
Chronic pyelonephritis
Laya Pillai
 

Viewers also liked (20)

Paediatric Urology [Dr.Edmond Wong]
Paediatric Urology [Dr.Edmond Wong]Paediatric Urology [Dr.Edmond Wong]
Paediatric Urology [Dr.Edmond Wong]
 
Hypospadias part 1 introd (step by step oper series)
Hypospadias part 1 introd   (step by step oper series) Hypospadias part 1 introd   (step by step oper series)
Hypospadias part 1 introd (step by step oper series)
 
Human Renal Transplantation [Dr. Edmond Wong]
Human Renal Transplantation [Dr. Edmond Wong]Human Renal Transplantation [Dr. Edmond Wong]
Human Renal Transplantation [Dr. Edmond Wong]
 
urinary tract infection
urinary tract infection urinary tract infection
urinary tract infection
 
Rough Draft
Rough DraftRough Draft
Rough Draft
 
SBAR Paper on Urosepsis and Dehydration
SBAR Paper on Urosepsis and DehydrationSBAR Paper on Urosepsis and Dehydration
SBAR Paper on Urosepsis and Dehydration
 
Hypospadias 2 orthoplasty & ttt options step by step oper series
Hypospadias 2 orthoplasty & ttt options   step by step oper series Hypospadias 2 orthoplasty & ttt options   step by step oper series
Hypospadias 2 orthoplasty & ttt options step by step oper series
 
Uti
UtiUti
Uti
 
Uti -for_non-urologists-uncomplicated and complicated
Uti  -for_non-urologists-uncomplicated and complicatedUti  -for_non-urologists-uncomplicated and complicated
Uti -for_non-urologists-uncomplicated and complicated
 
Uti and lab diagnosis
Uti and lab diagnosisUti and lab diagnosis
Uti and lab diagnosis
 
Ngu
NguNgu
Ngu
 
S ameer 2015 dysuria
S ameer 2015    dysuriaS ameer 2015    dysuria
S ameer 2015 dysuria
 
Hypospadias 3: MAGPI & snod grass (TIP) step by step operative urology series
Hypospadias 3: MAGPI & snod grass (TIP)   step by step operative urology series Hypospadias 3: MAGPI & snod grass (TIP)   step by step operative urology series
Hypospadias 3: MAGPI & snod grass (TIP) step by step operative urology series
 
Hypospadias
HypospadiasHypospadias
Hypospadias
 
Pyelonephritis csbrp
Pyelonephritis csbrpPyelonephritis csbrp
Pyelonephritis csbrp
 
URINARY SYSTEM DISORDERS of ROBB, FILAMER
URINARY SYSTEM DISORDERS of ROBB, FILAMERURINARY SYSTEM DISORDERS of ROBB, FILAMER
URINARY SYSTEM DISORDERS of ROBB, FILAMER
 
Cystitis
CystitisCystitis
Cystitis
 
Urine Interpretation / Test / Analysis
Urine Interpretation / Test / AnalysisUrine Interpretation / Test / Analysis
Urine Interpretation / Test / Analysis
 
Urethritis
UrethritisUrethritis
Urethritis
 
Chronic pyelonephritis
Chronic pyelonephritisChronic pyelonephritis
Chronic pyelonephritis
 

Similar to Urology infection [Dr. Edmond Wong]

1. urinary tract infection (UTI)
1. urinary tract infection (UTI)1. urinary tract infection (UTI)
1. urinary tract infection (UTI)
Mahadi Hassan Mahmoud Abdallah
 
Urinary Tract Infection Dr.Mahadi H Abdallah
Urinary Tract Infection  Dr.Mahadi H AbdallahUrinary Tract Infection  Dr.Mahadi H Abdallah
Urinary Tract Infection Dr.Mahadi H Abdallah
Mahadi Hassan Mahmoud Abdallah
 
Urinary Tract Infection- for medical personnel
Urinary Tract Infection- for medical personnelUrinary Tract Infection- for medical personnel
Urinary Tract Infection- for medical personnel
eetie
 
Bacterial infections of the urinary tract
Bacterial infections of the urinary tract Bacterial infections of the urinary tract
Bacterial infections of the urinary tract
Meher Rizvi
 
Urinary tract infections
Urinary tract infectionsUrinary tract infections
Urinary tract infections
jiya maria
 
Urinarytractinfections 120301095907-phpapp01
Urinarytractinfections 120301095907-phpapp01Urinarytractinfections 120301095907-phpapp01
Urinarytractinfections 120301095907-phpapp01
shaheen khowaja
 
UTI 01
UTI 01UTI 01
Recent trends in uti
Recent trends in utiRecent trends in uti
Recent trends in utiPavithra Dp
 
amoebiasis ppt.ppt
amoebiasis ppt.pptamoebiasis ppt.ppt
amoebiasis ppt.ppt
AlozieDavid1
 
Urinarytractinfections
UrinarytractinfectionsUrinarytractinfections
Urinarytractinfections
SUNIL KUMAR PEDDANA
 
therputics 2 chapter4 urinary tract infections noor batarseh.ppt
therputics 2 chapter4 urinary tract infections noor batarseh.ppttherputics 2 chapter4 urinary tract infections noor batarseh.ppt
therputics 2 chapter4 urinary tract infections noor batarseh.ppt
DuaaMichael
 
Mycobacterium tuberculosis
Mycobacterium tuberculosisMycobacterium tuberculosis
Mycobacterium tuberculosis
subhalakshmi ramakrishnan
 
STOOL EXAMINATION.pdf
STOOL EXAMINATION.pdfSTOOL EXAMINATION.pdf
STOOL EXAMINATION.pdf
chandreshmishra13
 
URINARY TRACT INFECTION
URINARY TRACT INFECTIONURINARY TRACT INFECTION
URINARY TRACT INFECTION
Sukreetysilwal
 
Urinary tract infection
Urinary tract infectionUrinary tract infection
Urinary tract infection
ajayyadav753
 

Similar to Urology infection [Dr. Edmond Wong] (20)

Uti case ped
Uti case pedUti case ped
Uti case ped
 
1. urinary tract infection (UTI)
1. urinary tract infection (UTI)1. urinary tract infection (UTI)
1. urinary tract infection (UTI)
 
Urinary Tract Infection Dr.Mahadi H Abdallah
Urinary Tract Infection  Dr.Mahadi H AbdallahUrinary Tract Infection  Dr.Mahadi H Abdallah
Urinary Tract Infection Dr.Mahadi H Abdallah
 
Urinary tract infections
Urinary tract infectionsUrinary tract infections
Urinary tract infections
 
UTI.pdf
UTI.pdfUTI.pdf
UTI.pdf
 
Urinary Tract Infection- for medical personnel
Urinary Tract Infection- for medical personnelUrinary Tract Infection- for medical personnel
Urinary Tract Infection- for medical personnel
 
Urinary Tract Infections
Urinary Tract InfectionsUrinary Tract Infections
Urinary Tract Infections
 
Bacterial infections of the urinary tract
Bacterial infections of the urinary tract Bacterial infections of the urinary tract
Bacterial infections of the urinary tract
 
Urinary tract infections
Urinary tract infectionsUrinary tract infections
Urinary tract infections
 
Urinarytractinfections 120301095907-phpapp01
Urinarytractinfections 120301095907-phpapp01Urinarytractinfections 120301095907-phpapp01
Urinarytractinfections 120301095907-phpapp01
 
UTI 01
UTI 01UTI 01
UTI 01
 
Recent trends in uti
Recent trends in utiRecent trends in uti
Recent trends in uti
 
amoebiasis ppt.ppt
amoebiasis ppt.pptamoebiasis ppt.ppt
amoebiasis ppt.ppt
 
Urinarytractinfections
UrinarytractinfectionsUrinarytractinfections
Urinarytractinfections
 
therputics 2 chapter4 urinary tract infections noor batarseh.ppt
therputics 2 chapter4 urinary tract infections noor batarseh.ppttherputics 2 chapter4 urinary tract infections noor batarseh.ppt
therputics 2 chapter4 urinary tract infections noor batarseh.ppt
 
Mycobacterium tuberculosis
Mycobacterium tuberculosisMycobacterium tuberculosis
Mycobacterium tuberculosis
 
STOOL EXAMINATION.pdf
STOOL EXAMINATION.pdfSTOOL EXAMINATION.pdf
STOOL EXAMINATION.pdf
 
Urethritis seminar
Urethritis seminarUrethritis seminar
Urethritis seminar
 
URINARY TRACT INFECTION
URINARY TRACT INFECTIONURINARY TRACT INFECTION
URINARY TRACT INFECTION
 
Urinary tract infection
Urinary tract infectionUrinary tract infection
Urinary tract infection
 

More from Edmond Wong

Emergency in Urology [Dr. Edmond Wong]
Emergency in Urology [Dr. Edmond Wong]Emergency in Urology [Dr. Edmond Wong]
Emergency in Urology [Dr. Edmond Wong]
Edmond Wong
 
Neurogenic bladder [Dr. Edmond Wong]
Neurogenic bladder [Dr. Edmond Wong]Neurogenic bladder [Dr. Edmond Wong]
Neurogenic bladder [Dr. Edmond Wong]
Edmond Wong
 
Muscle invasive bladder Cancer [Dr.Edmond Wong]
Muscle invasive bladder Cancer [Dr.Edmond Wong]Muscle invasive bladder Cancer [Dr.Edmond Wong]
Muscle invasive bladder Cancer [Dr.Edmond Wong]
Edmond Wong
 
Urinary Stone Management [Dr. Edmond Wong]
Urinary Stone Management [Dr. Edmond Wong]Urinary Stone Management [Dr. Edmond Wong]
Urinary Stone Management [Dr. Edmond Wong]
Edmond Wong
 
Bladder Cancer NMIBC [Dr.Edmond Wong]
Bladder Cancer NMIBC [Dr.Edmond Wong]Bladder Cancer NMIBC [Dr.Edmond Wong]
Bladder Cancer NMIBC [Dr.Edmond Wong]
Edmond Wong
 
Urology New Technology and Imaging [Dr.Edmond Wong]
Urology New Technology and Imaging [Dr.Edmond Wong]Urology New Technology and Imaging [Dr.Edmond Wong]
Urology New Technology and Imaging [Dr.Edmond Wong]
Edmond Wong
 
Urinary Diversion after cystectomy [Dr.Edmond Wong]
Urinary Diversion after cystectomy  [Dr.Edmond Wong]Urinary Diversion after cystectomy  [Dr.Edmond Wong]
Urinary Diversion after cystectomy [Dr.Edmond Wong]
Edmond Wong
 
Upper Tract Transitional Cell Carcinoma [Dr. Edmond Wong]
Upper Tract Transitional Cell Carcinoma [Dr. Edmond Wong]Upper Tract Transitional Cell Carcinoma [Dr. Edmond Wong]
Upper Tract Transitional Cell Carcinoma [Dr. Edmond Wong]
Edmond Wong
 
Erectile Dysfunction [Dr. Edmond Wong]
Erectile Dysfunction [Dr. Edmond Wong]Erectile Dysfunction [Dr. Edmond Wong]
Erectile Dysfunction [Dr. Edmond Wong]
Edmond Wong
 
Testicular ca [edmond]
Testicular ca [edmond]Testicular ca [edmond]
Testicular ca [edmond]
Edmond Wong
 
Ca penis [edmond]
Ca penis [edmond]Ca penis [edmond]
Ca penis [edmond]
Edmond Wong
 
Ca kidney [edmond]
Ca kidney [edmond]Ca kidney [edmond]
Ca kidney [edmond]
Edmond Wong
 
Ca prostate [edmond]
Ca prostate [edmond]Ca prostate [edmond]
Ca prostate [edmond]
Edmond Wong
 

More from Edmond Wong (13)

Emergency in Urology [Dr. Edmond Wong]
Emergency in Urology [Dr. Edmond Wong]Emergency in Urology [Dr. Edmond Wong]
Emergency in Urology [Dr. Edmond Wong]
 
Neurogenic bladder [Dr. Edmond Wong]
Neurogenic bladder [Dr. Edmond Wong]Neurogenic bladder [Dr. Edmond Wong]
Neurogenic bladder [Dr. Edmond Wong]
 
Muscle invasive bladder Cancer [Dr.Edmond Wong]
Muscle invasive bladder Cancer [Dr.Edmond Wong]Muscle invasive bladder Cancer [Dr.Edmond Wong]
Muscle invasive bladder Cancer [Dr.Edmond Wong]
 
Urinary Stone Management [Dr. Edmond Wong]
Urinary Stone Management [Dr. Edmond Wong]Urinary Stone Management [Dr. Edmond Wong]
Urinary Stone Management [Dr. Edmond Wong]
 
Bladder Cancer NMIBC [Dr.Edmond Wong]
Bladder Cancer NMIBC [Dr.Edmond Wong]Bladder Cancer NMIBC [Dr.Edmond Wong]
Bladder Cancer NMIBC [Dr.Edmond Wong]
 
Urology New Technology and Imaging [Dr.Edmond Wong]
Urology New Technology and Imaging [Dr.Edmond Wong]Urology New Technology and Imaging [Dr.Edmond Wong]
Urology New Technology and Imaging [Dr.Edmond Wong]
 
Urinary Diversion after cystectomy [Dr.Edmond Wong]
Urinary Diversion after cystectomy  [Dr.Edmond Wong]Urinary Diversion after cystectomy  [Dr.Edmond Wong]
Urinary Diversion after cystectomy [Dr.Edmond Wong]
 
Upper Tract Transitional Cell Carcinoma [Dr. Edmond Wong]
Upper Tract Transitional Cell Carcinoma [Dr. Edmond Wong]Upper Tract Transitional Cell Carcinoma [Dr. Edmond Wong]
Upper Tract Transitional Cell Carcinoma [Dr. Edmond Wong]
 
Erectile Dysfunction [Dr. Edmond Wong]
Erectile Dysfunction [Dr. Edmond Wong]Erectile Dysfunction [Dr. Edmond Wong]
Erectile Dysfunction [Dr. Edmond Wong]
 
Testicular ca [edmond]
Testicular ca [edmond]Testicular ca [edmond]
Testicular ca [edmond]
 
Ca penis [edmond]
Ca penis [edmond]Ca penis [edmond]
Ca penis [edmond]
 
Ca kidney [edmond]
Ca kidney [edmond]Ca kidney [edmond]
Ca kidney [edmond]
 
Ca prostate [edmond]
Ca prostate [edmond]Ca prostate [edmond]
Ca prostate [edmond]
 

Recently uploaded

KDIGO 2024 guidelines for diabetologists
KDIGO 2024 guidelines for diabetologistsKDIGO 2024 guidelines for diabetologists
KDIGO 2024 guidelines for diabetologists
د.محمود نجيب
 
Role of Mukta Pishti in the Management of Hyperthyroidism
Role of Mukta Pishti in the Management of HyperthyroidismRole of Mukta Pishti in the Management of Hyperthyroidism
Role of Mukta Pishti in the Management of Hyperthyroidism
Dr. Jyothirmai Paindla
 
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTSARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
Dr. Vinay Pareek
 
How STIs Influence the Development of Pelvic Inflammatory Disease.pptx
How STIs Influence the Development of Pelvic Inflammatory Disease.pptxHow STIs Influence the Development of Pelvic Inflammatory Disease.pptx
How STIs Influence the Development of Pelvic Inflammatory Disease.pptx
FFragrant
 
SURGICAL ANATOMY OF THE RETROPERITONEUM, ADRENALS, KIDNEYS AND URETERS.pptx
SURGICAL ANATOMY OF THE RETROPERITONEUM, ADRENALS, KIDNEYS AND URETERS.pptxSURGICAL ANATOMY OF THE RETROPERITONEUM, ADRENALS, KIDNEYS AND URETERS.pptx
SURGICAL ANATOMY OF THE RETROPERITONEUM, ADRENALS, KIDNEYS AND URETERS.pptx
Bright Chipili
 
The Electrocardiogram - Physiologic Principles
The Electrocardiogram - Physiologic PrinciplesThe Electrocardiogram - Physiologic Principles
The Electrocardiogram - Physiologic Principles
MedicoseAcademics
 
Basavarajeeyam - Ayurvedic heritage book of Andhra pradesh
Basavarajeeyam - Ayurvedic heritage book of Andhra pradeshBasavarajeeyam - Ayurvedic heritage book of Andhra pradesh
Basavarajeeyam - Ayurvedic heritage book of Andhra pradesh
Dr. Madduru Muni Haritha
 
CDSCO and Phamacovigilance {Regulatory body in India}
CDSCO and Phamacovigilance {Regulatory body in India}CDSCO and Phamacovigilance {Regulatory body in India}
CDSCO and Phamacovigilance {Regulatory body in India}
NEHA GUPTA
 
Thyroid Gland- Gross Anatomy by Dr. Rabia Inam Gandapore.pptx
Thyroid Gland- Gross Anatomy by Dr. Rabia Inam Gandapore.pptxThyroid Gland- Gross Anatomy by Dr. Rabia Inam Gandapore.pptx
Thyroid Gland- Gross Anatomy by Dr. Rabia Inam Gandapore.pptx
Dr. Rabia Inam Gandapore
 
A Classical Text Review on Basavarajeeyam
A Classical Text Review on BasavarajeeyamA Classical Text Review on Basavarajeeyam
A Classical Text Review on Basavarajeeyam
Dr. Jyothirmai Paindla
 
Gram Stain introduction, principle, Procedure
Gram Stain introduction, principle, ProcedureGram Stain introduction, principle, Procedure
Gram Stain introduction, principle, Procedure
Suraj Goswami
 
Cardiac Assessment for B.sc Nursing Student.pdf
Cardiac Assessment for B.sc Nursing Student.pdfCardiac Assessment for B.sc Nursing Student.pdf
Cardiac Assessment for B.sc Nursing Student.pdf
shivalingatalekar1
 
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness JourneyTom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
greendigital
 
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptxANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
Swetaba Besh
 
Top 10 Best Ayurvedic Kidney Stone Syrups in India
Top 10 Best Ayurvedic Kidney Stone Syrups in IndiaTop 10 Best Ayurvedic Kidney Stone Syrups in India
Top 10 Best Ayurvedic Kidney Stone Syrups in India
SwastikAyurveda
 
micro teaching on communication m.sc nursing.pdf
micro teaching on communication m.sc nursing.pdfmicro teaching on communication m.sc nursing.pdf
micro teaching on communication m.sc nursing.pdf
Anurag Sharma
 
Knee anatomy and clinical tests 2024.pdf
Knee anatomy and clinical tests 2024.pdfKnee anatomy and clinical tests 2024.pdf
Knee anatomy and clinical tests 2024.pdf
vimalpl1234
 
Colonic and anorectal physiology with surgical implications
Colonic and anorectal physiology with surgical implicationsColonic and anorectal physiology with surgical implications
Colonic and anorectal physiology with surgical implications
Dr Maria Tamanna
 
NVBDCP.pptx Nation vector borne disease control program
NVBDCP.pptx Nation vector borne disease control programNVBDCP.pptx Nation vector borne disease control program
NVBDCP.pptx Nation vector borne disease control program
Sapna Thakur
 
Aortic Association CBL Pilot April 19 – 20 Bern
Aortic Association CBL Pilot April 19 – 20 BernAortic Association CBL Pilot April 19 – 20 Bern
Aortic Association CBL Pilot April 19 – 20 Bern
suvadeepdas911
 

Recently uploaded (20)

KDIGO 2024 guidelines for diabetologists
KDIGO 2024 guidelines for diabetologistsKDIGO 2024 guidelines for diabetologists
KDIGO 2024 guidelines for diabetologists
 
Role of Mukta Pishti in the Management of Hyperthyroidism
Role of Mukta Pishti in the Management of HyperthyroidismRole of Mukta Pishti in the Management of Hyperthyroidism
Role of Mukta Pishti in the Management of Hyperthyroidism
 
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTSARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
 
How STIs Influence the Development of Pelvic Inflammatory Disease.pptx
How STIs Influence the Development of Pelvic Inflammatory Disease.pptxHow STIs Influence the Development of Pelvic Inflammatory Disease.pptx
How STIs Influence the Development of Pelvic Inflammatory Disease.pptx
 
SURGICAL ANATOMY OF THE RETROPERITONEUM, ADRENALS, KIDNEYS AND URETERS.pptx
SURGICAL ANATOMY OF THE RETROPERITONEUM, ADRENALS, KIDNEYS AND URETERS.pptxSURGICAL ANATOMY OF THE RETROPERITONEUM, ADRENALS, KIDNEYS AND URETERS.pptx
SURGICAL ANATOMY OF THE RETROPERITONEUM, ADRENALS, KIDNEYS AND URETERS.pptx
 
The Electrocardiogram - Physiologic Principles
The Electrocardiogram - Physiologic PrinciplesThe Electrocardiogram - Physiologic Principles
The Electrocardiogram - Physiologic Principles
 
Basavarajeeyam - Ayurvedic heritage book of Andhra pradesh
Basavarajeeyam - Ayurvedic heritage book of Andhra pradeshBasavarajeeyam - Ayurvedic heritage book of Andhra pradesh
Basavarajeeyam - Ayurvedic heritage book of Andhra pradesh
 
CDSCO and Phamacovigilance {Regulatory body in India}
CDSCO and Phamacovigilance {Regulatory body in India}CDSCO and Phamacovigilance {Regulatory body in India}
CDSCO and Phamacovigilance {Regulatory body in India}
 
Thyroid Gland- Gross Anatomy by Dr. Rabia Inam Gandapore.pptx
Thyroid Gland- Gross Anatomy by Dr. Rabia Inam Gandapore.pptxThyroid Gland- Gross Anatomy by Dr. Rabia Inam Gandapore.pptx
Thyroid Gland- Gross Anatomy by Dr. Rabia Inam Gandapore.pptx
 
A Classical Text Review on Basavarajeeyam
A Classical Text Review on BasavarajeeyamA Classical Text Review on Basavarajeeyam
A Classical Text Review on Basavarajeeyam
 
Gram Stain introduction, principle, Procedure
Gram Stain introduction, principle, ProcedureGram Stain introduction, principle, Procedure
Gram Stain introduction, principle, Procedure
 
Cardiac Assessment for B.sc Nursing Student.pdf
Cardiac Assessment for B.sc Nursing Student.pdfCardiac Assessment for B.sc Nursing Student.pdf
Cardiac Assessment for B.sc Nursing Student.pdf
 
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness JourneyTom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
 
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptxANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
 
Top 10 Best Ayurvedic Kidney Stone Syrups in India
Top 10 Best Ayurvedic Kidney Stone Syrups in IndiaTop 10 Best Ayurvedic Kidney Stone Syrups in India
Top 10 Best Ayurvedic Kidney Stone Syrups in India
 
micro teaching on communication m.sc nursing.pdf
micro teaching on communication m.sc nursing.pdfmicro teaching on communication m.sc nursing.pdf
micro teaching on communication m.sc nursing.pdf
 
Knee anatomy and clinical tests 2024.pdf
Knee anatomy and clinical tests 2024.pdfKnee anatomy and clinical tests 2024.pdf
Knee anatomy and clinical tests 2024.pdf
 
Colonic and anorectal physiology with surgical implications
Colonic and anorectal physiology with surgical implicationsColonic and anorectal physiology with surgical implications
Colonic and anorectal physiology with surgical implications
 
NVBDCP.pptx Nation vector borne disease control program
NVBDCP.pptx Nation vector borne disease control programNVBDCP.pptx Nation vector borne disease control program
NVBDCP.pptx Nation vector borne disease control program
 
Aortic Association CBL Pilot April 19 – 20 Bern
Aortic Association CBL Pilot April 19 – 20 BernAortic Association CBL Pilot April 19 – 20 Bern
Aortic Association CBL Pilot April 19 – 20 Bern
 

Urology infection [Dr. Edmond Wong]

  • 2. Outline • Definition • Bacteriology • Cystitis & urethritis • Recurrent UTI • Pyelonephritis, EPN & XGP • General principles of antibiotic and prophylaxis • Mx of septicaemia • TB urinary tract • Prostatitis • Epididymal orchitis • Viral disease of Genital tract (condylomata, AIDS, Herpes) • Schistosomiasis • Radiation cystitis • Chemical cystitis and mx • Antibiotic prophylaxis in uro procedure
  • 3. Definition • Bacteriuria: Presence of bacteria in urine • Pyuria: presence of WBC in urine • Sterile Pyuria: Pyuria without bacteriuria 1. Incomplete antimicrobial treatment of UTI 2. Infections caused by Mycobacterium tuberculosis and other fastidious bacteria, e.g. Chlamydia trachomatis 3. Urolithiasis and foreign bodies 4. CIS 5. Interstitial cystitis 6. schistosomiasis
  • 4. Definition • Cystitis: – Clinical syndrome of dysuria, frequency & urgency +/- Bladder pain • Acute pyelonephritis: – Syndrome of Fever, Chills & rigor, flank pain , bacteriuria + pyuria • Chronic pyelonephritis: – Radiological diagnosis – Scarred , shrunkened kidney (may or maynot result from recurrence infection)
  • 5. What is the definition of UTI? • UTI – Inflammatory response of urothelium to microorganism invasion, commonly bacteria , associated with pyuria and bacteriuria • Opportunistic infection : infection caused by non-pathogens (commensals) due to weakened host defence mechanisms
  • 6. Definition of UTI • Isolated UTI: – Occur at least 6m after the previous UTI • Recurrent UTI : >=2 UTI in 6m / >=3 UTIs in 1yr – Bacterial persistence: UTI by same organism • Nidus (stone, bladder/urethral diverticulum, chronic prostatitis, colo-vesical fistula) – Reinfection: by different organisms each time • Increased susceptibility to UTI, e.g. poor hygiene, sexual intercourse, post menopause • > 95% female recurrent UTI is reinfection
  • 7. Definitions of UTI • Unresolved infection: not response to txn 1. Bacterial resistence to antibiotic 2. Development of resistance in a previously susceptible organism 3. Multiple organism 4. Rapid re-infection & overwhelming pathogens 5. Subtherapeutic level of antimicrobial 6. Non-compliance with treatment
  • 8. Definition of UTI: • Complicated UTI – Structurally and functionally abnormal urinary tract – Underlying disease prone to complicated UTI 1. Male gender , elderly 2. Pregnancy 3. Catheter or stent or instrumentation 4. immunocompromised, DM, hospital acquired infection • uncomplicated UTI – No structurally and functionally abnormal urinary tract – No underlying disease prone to acquire UTI
  • 9. How does the urinary dipstick –How does the urinary dipstick – (blood) work?(blood) work? • Chromogen indicator : orthotolidine is a peroxidase substrate • Haemoglobin has peroxidase activity • Oxidation process take place • Positive result : BLUE • False positive (oxidasing agent): 1. Povidone iodine 2. Hypochlorite (bleach) 3. Menstrual blood 4. Dehydration, exercise and myoglobin • False negative (reducing agent): – Vitamin C – Poorly mixed urine • Dipstick positive but microscopy negative – dilute urine
  • 10. How does the urinary dipstick –How does the urinary dipstick – (WBC) work?(WBC) work? • Neutrophils produce leucocyte esterase • Catalyzes the hydrolysis of a indoxyl carbonic acid ester to indoxyl • Idoxyl oxidise the diazonium salt chromogen to produce blue colour • False positive : vaginal discharge or formalin • False negative (reducing agent) 1. Vitamin C 2. Dehydration 3. Glycosuria, urobilinogen 4. Test is read too fast (< 2min) or too long (lysis of WBC) • 30% of infection with negative leucocyte esterase ( = 70% sensitivity)
  • 11. How does the urinary dipstick –How does the urinary dipstick – (nitrites) work?(nitrites) work? • Gram negative bacteria convert nitrates to nitrites (not usually in urine) • Nitrite react with the aromatic amine to form diazonium salt • Which react with hydroxybenzoquinolone to form pink colour (Griess reaction) – 4 hours processing • High specificity but low sensitivity – means +ve  UTI, negative cannot rule out UTI • When negative for both nitrites and leukocytes 90% of MSU will be negative for significant bacteriuria • When positive for both nitrites and leucocytes, 80% will have positive cultures on MSU – More specific but less sensitive to either test alone • False positive – contamination • False negative – gram positive bacteria, pseudomonas, ascorbic acid, and dilute urine, urine in bladder < 4 hours (so only early morning urine is reliable)
  • 12. Why is urine pH important? • Normal urinary pH: 5.5- 6.5 • pH> 7.5  possibility of stone • Urea splitting organism produce urease: (PKS, PPS) 1. Proteus 2. Klebsiella 3. Staphylococcus 4. Pseudomonas 5. Providencia 6. Serratia • Induce following reaction: – Urea  CO2 + NH3 (ammonia) – NH3 raise pH – Precipitation of magnesium ammonium phosphate to form staghorn stone
  • 14. What are the definitions of significant bacteriuria? • Kass first introduced quantitative microbiology in diagnosis UTI – Significant bacteriuria ≥ 105 cfu/mL of pure growth – However, miss 1/3 symptomatic UTI with growth ≥ 103 cfu/mLof pure growth • > 103 : uncomplicated cystitis in women • > 104 : uncomplicated pyelonephrisitis in women, catheter urine in women, men • Asymptomatic bacteriuria should be treated in children, pregnant female and immunocompromized patents, prior to an invasive genitourinary procedure for which there is a risk of mucosal bleeding, but not DM or elderly patient (Canada’s study)
  • 15. What is the implication of bacteriuria? • A single in/out uretheral catheterization may be complicated by bacteriuria in 5% of cases • Bacteriuria is almost universal when the catheter is left in situ for longer than 3 days • 10-20% of patients with pyelonephritis have bacteriuria • Bacteriuria without pyuria may be found – bacterial contamination – Colonization (asymptomatic bacteriuria) • Absence of pyuria may cause doubt on the diagnosis of UTI
  • 16.
  • 17. Risk factor for bacteriuria 1. Female 2. Low oestrogen state (menopause) 3. Pregnancy 4. Age 5. Institutional state in elderly 6. Indwelling catheters 7. Previous UTI 8. DM 9. Stone disease 10.GU malformation & voiding dysfunction (including obstruction)
  • 18. How would you instruct the pt for MSU? • Women: – Spread the labia – Wash and cleanse the periurethral area with moist gauze from back to front – Void first 100-150ml , collect next 10-15ml • Men: – Circumcised: no special preparation – Uncircumcised: • Retract foreskin , wash glans with soap and rinse with water • Keep foreskin retracted: collect 10-15ml • Handling of MSU: – Culture with hours or refrigerated immediately & culture within 24hr – Microscopy: 5-10ml urine centrifuge for 5min (2000rpm) – Culture: 0.1ml urine of split-agar plate • Blood agar  gram +ve culture • Eosinmethylene blue (EMB)  gram –ve culture • Estimate CFU after overnight incubation
  • 19. What is the gram’s stain? • Bacterial smear is stained with crystal violet for 1- 2min then pour off • Then Gram’s iodine for 1-2min then pour off • Decolorized by acetone • Washed with water and counterstained with safranin for 2 mins • Gram +ve: cell wall that retain the crystal violet dye – MRSA is a gram +ve coccus. It is present on the skin of about 40% of people. Over 90% of isolates produce the penicillin binding protein which makes the strain resistant to penicillin base antibiotics • G-ve – pink safranin
  • 20.
  • 22. Why patient will have UTI? • An interaction of susceptibility of host & virulence of organism • Pathogenicity: ability of an organsim to cause disease • Virulence: degree of pathogenicity – Characteristics of uropathogens to colonised and flourish within the host
  • 23. Bacterial virulence factors? • Directed against external agents (i.e antimicrobial resistence) – Inherited chromosomally (intrinsic resistance of proteus to nitrofurnatoin) • Enzyme inactivation: beta-lactamase which hydrolyses the beta-lactam bone within penicillin gp of antibiotic • Secrete by S. aureus , gonorrhoea & enterobacteria – Acquired chromosomally (mutations) • Alter the antibiotic target & receptor activity – Acquire extra-chromosomally (plasmids)
  • 24. Direct against host: 1. General: extracellular capsule prevent phagocytosis (E coli) 2. Toxin, e.g. haemolysin 3. Enzyme, e.g. urease 4. Antihumoral factors, e.g. IgA inactiviting protein by gonorrhoea and Proteus 5. Adherence mechanism – afimbrial or fimbrial types (E.coli) – Afimbrial adhesin – Dr adhesins (UTI in children and pregnancy) – Fimbriase: 100 pili, 5nm diameter , 2um long – Type P fimbriae (mannose resistant) have adhesions that bind to renal urothelium and are associated with >90% of pyelonephritis – Type P fimbriae are more virulent and more adhesive than type 1 fimbriae – Type 1 fimbriae (mannose sensitive) binds to elements of bladder urothelium and are associated with cystitis – Type 1 fimbriae are also referred to as mannose sensitive. This means that fimbriae have the ability to adhere to and agglutinate guinea pig erythrocytes. Such an event is inhibited by mannose – S pili – both bladder and kidney infection 6. Others – Penetration of host by schistosoma apine – Intrinsic resistance of Proteus to nitrofurantoin
  • 25. What are normal host defence mechanisms against UTI? 1. Normal commersal flora of vaginal introitus and periurethral area – Lactobacilli reduced uropathogens to colonise by lowering pH as a result of converting glycogen to lactic acid (lower pH) 2. Vaginal oestrogen and IgA 3. Normal antegrade flow of urine 4. Characteristic of urine (high osmolality, low pH, Urea , etc) 5. Mechnical integrity of mucous membrane 6. Normal exfoliation of urothelial cells 7. Tamm-horsfall protein by ascending limb of loop of Henle – bind type 1 pili & prevent attachment 8. GAG (Glycosiaminoglycan) layer
  • 26. Route of infection • Ascending infection (majority) – Bacteria colonize perineum, vagina & distal urethra – Ascend to bladder (cystitis) – Ascend to kidney (pyelonephritis), encourage by reflux • Hematogenous (uncommon): – Staph aureus, candida, fungaemia & TB • Via lymphatics: – Inflammatory bowel disease – Retroperitoneal abscess
  • 28.
  • 29.
  • 30. Anbitiotic Formulary • TMP-SMX—inhibits dihydrofolic acid reductase – Enterococcus and Pseudomonas are resistant • Nitrofurantoin—mechanism unknown – Pseudomonas and Proteus resistant, not useful in upper tract infections, development of resistance very low • Cephalosporins—1st to 3rd generation increases Gram negative and anaerobic coverage • Aminopenicillins—effective enterococcus, 30% resistance development in common uropathogen isolates. • Aminoglycoside—combined with ampicillin 1st line therapy for urosepsis, nephrotoxic • Flouroquinolone—DNA gyrase inhibitor, enterococcus resistant, damages cartilage in animal studies
  • 32. Uncomplicated Cystitis • Absence of physiologic or anatomic abnormalities & no recent urologic surgery • 30% of women between age 20-40 have had a UTI – 80% E. coli – 15% S. Saprophyticus • Rarely occurs in men – Uncircumcised – HIV
  • 33. Uncomplicated Cystitis • Microscopic analysis is more sensitive than dip-stick testing – Bacteriuria – Pyuria – Hematuria Symptoms: – Dysuria, frequency, urgency, small urine volumes, suprapubic pain • Differential Diagnosis: – Vaginitis – Urethral infection / urethritis – STD
  • 34. Uncomplicated Cystitis • Pretherapy urine Cx only for the following: – Dx in doubt – Symptoms longer than 7 days – Older than age 65 – DM – Pregnancy – All males • Treatment (3-days): – TMP-SMX – TMP alone – Nitrofurantoin – Fluoroquinolones (use for patients with allergy to less costly drugs or with high risk of infection with resistant organism) – Amoxicillin- Clavulanate during pregnancy
  • 35. Urethritis • Inflammation of urethra • Men: STD with dysuria + urethral discharge • Gonococcal urethritis (GU) – gram-negative diplococcus Neisseria gonorrhoea (incubation 10 day) – concomitant infection with Chlamydia trachomatis – Investigation: urethral swab for C/ST – Treatment: • ceftriaxone 125 mg IM in a single dose • cefixime 400 mg orally in a single dose • plus treatment for chlamydia • Quionolone is not recommended • Non gonococcal urethritis (NGU) – Chlamydia trachomatis (incubation 1–5 weeks) – Azithromycin, 1 g as a single oral dose – Doxycycline, 100 mg orally twice a day for 7 days – Transmission to females results in increased risk of pelvic inflammatory disease, abdominal pain, ectopic pregnancy, infertility, and perinatal infection
  • 36. • Gonococci located intracellularly as Gram- negative diplococci • Ciprofloxacin (gonococci) and doxycycline (chlamydial) for 2 weeks if young epididymoorchitis • Fluoroquinolones are contraindicated in adolescents (< 18 years) and pregnant women
  • 37. Recurrent UTI inRecurrent UTI in femalefemale
  • 38. Female refer for recurrent UTI , what is your approach? • History: – Age – Isolated or recurrent UTI? – Trace all previous MSU result – Re-infection or persistence? – Number of confirmed UTI in one year – Cystitis or pyelonephritis? – Complicated or uncomplicated infection? – Hematuria (CIS) • PMH: – Marital and obs hx – OCP – STD – DM – TB – Stone – Constipation – Neurological illness – Previous UTI in childhood • Family hx of UTI – ABO bld gp Ag non-secretors – Lewis non-secretor – P bld gp secretors
  • 39. PE • Abd: – Palpable kidney – Palpable bladder – Loin pain • Vaginal examine: – State of oestrogenisation – Genital prolapse – Urethral diverticulum • Focused neurological examination
  • 40.
  • 42. Despite all investigation, no cause of infection identify, what can you explain to her ?
  • 43. Why do women increase risk of recurrent infection? Susceptibility to infections 1. Increased number of receptors sites for uropathogen 2. Shorter urethra 3. Close proximity to anus 4. Asymptomatic bacteriuria in pregnant women 5. Large PVR in older women 6. Genital prolapse 7. P blood group secretor / ABO blood group non- secretor / Lewis non-secretor 8. HLA-A3 phenotype
  • 44. What are the risk factors ofWhat are the risk factors of recurrent UTI?recurrent UTI? 1. Reduce antegrade flow of urine (low fluid intake, BOO, neurogenic bladder) 2. Sexual intercourse 3. Use of spermicides 4. Urinary and fecal incontinence 5. Atrophic vaginitis • Raz (NEJM 1993) published a small randomized trial of 93 post menopausal female with recurrent urinary tract infections and reported a significant reduction in the frequency of UTI’s in ladies treated with topical estriol 6. History of UTI 7. Immumocompromised, e.g. DM / HIV
  • 45. Mx of recurrent UTI : general measure Aim: control symptom & reduce frequency of infection • High fluid intake • Void before and after sexual intercourse (vigorous activity may “milk” the bacteria to the bladder) • Avoid using detergents in her bath • Avoid using spermicidal contraceptive • Apply lactobacilli to vagina to keep her urine acidic • Apply oestrogen to atrophic vagina to restore normal vaginal environment and recolonisation with lactobacilli • Cranberry juice (proanthocyanidin) – block bacterial adherence to urothelium, 20% reduction risk of infection
  • 46. Treatment strategies • < 3 UTI / year: patient initiated therpay • > 3 UTI/ year: prophylaxis for 6/12 • Post-coital single dose therapy
  • 47. Mx: Antibiotic 3 regimens available: • Low dose long-term continuous antibiotics: – Eliminate introitoal and enteric reservoir, does not cause resistant – Trimethoprim (100mg) , cephalexin (250mg) ,nitrofurantoin(50mg) QD – Break thru infection txn with course of A/B, then restart prophylaxis – 6-12 months, 95% reduction of recurrence, but 60% reinfected after stopping the antibiotics • Postcoital antimicrobial prophylaxis – Ciprofloxacin 125 mg once daily – Nitrofurantoin 50 mg once daily – lower systemic absorption and less microbial resistance, but avoided in pyelonephritis as tissue level in kidney is low – Avoid amoxicillin and cephalosporin which change fecal flora • Intermittency self-start therapy: – Recurrent uncomplicated cystitis – 3-day course regimen of an antimicrobial with MSU beforehand – If failed > send MSU for proper culture – 1 week course if symptom persist or for men
  • 48. • Trimethoprim: – Eradicate gram –ve aerobic from gut and vaginal fluid (eradicate source) – Batericidal concentration in urine – Adverse: GI disturbance, mylotoxicity, erythema multiforme, TEN, photosensitivity – Cautions in renal impairment • Nitrofurantonin: – No effect on gut flora – High concentration in urine  elimination of bacteria – Would not induce bacterial resistance – Adverse: Pulmonary fibrosis , peripheral neruopathy, agranulocytosis , liver damage • Cefalexin: – Would not induce resistance – Adverse: GI upset , allergic rxn • Fluoroguinolones : – Short course eradicate enterobacteria from faecal & vaginal flora – Adverse reaction: tendon rupture in 48 hour (esp with concomittent use of steriod) , GI , Steven-Johnson syndrome
  • 49. Mx if bacterial persistent • Identify potential cause: – KUB (stone) – Renal USG (hydronephrosis, stone) – FR + RU – IVU or CTU – FC (bladder stone, Ca bladder, urethral or BNS , fistula) • Txn: treat underlying cause
  • 50. Acute and chronicAcute and chronic pyelonephritispyelonephritis
  • 51. Acute pyelonephritis • Inflammation of the kidney and renal pelvis • Presentation: – Fever, chills rigor – Flank pain and tenderness – Lower UTI symptom – Unilateral or bilateral • Ddx: cholecystitis, pancreatitis, diverticulitis, apendicitis • Risk factor: – Female – VUR, Urinary tract obstruction or Neuopathetic bladder – DM, immunocompromised state – Congenital malformation – Pregnancy – Catheter and instrumentation
  • 52. Acute pyelonephritis • Pathology: – Patchy infiltration of neutrophil & bacteria in parenchyma – Inflammatory band extending to cortex – Small cortical abscess (80%) • Organism: E.coli , enterococci, klebsiella , proteus, pseudomonas • Investigation: – Bld – KUB – MSU – USG if derange RFT
  • 53. Radiologic Findings • Generalized renal enlargement – Overall length of 15cm – 1.5cm greater length on the the affected side • Focal renal enlargement – Renal mass • Cortical striations during the nephrogram phase of the urogram (perinephric stranding) • Dilatation of ureter/pelvis
  • 54.
  • 55. Treatment • Not systemically unwell : oral cirprofloxacin 500mg BD for 10 days • Systemically unwell: – IVF – IV antibiotic (quinolone +/- gentamicin) • Change to oral antibiotic after afebrile • Complete antitbiotic for 14 days intotal
  • 56. Is it necessary to perform upper tract imaging? • If the patients remain febrile after 72 h of treatment • Evaluation of the upper urinary tract with ultrasound should be performed to rule out abscess, urinary obstruction • CTU: pyonephrosis, perinephric abscess , emphysematous pyelonephritis, Stone • Chronic pyelonephritis – scarred shrunken kidney
  • 57. What is the antibiotic of choice? • Augmentin is not recommended as a drug of first choice for empirical oral therapy of acute pyelonephritis. It is recommended when susceptibility testing shows a susceptible Gram- positive organism • In communities with high rates of fluoroquinolone- resistant and extended-spectrum β-lactamase (ESBL)-producing E. coli, initial empirical therapy with an aminoglycoside or carbapenem has to be considered until susceptibility testing demonstrates that oral drugs can also be used
  • 58. Chronic Pyelonephritis • Dx: Radiologic, Pathologic – Radiographically scarred & shrunken • Often no history of UTI – Bacterial antigens detectable in renal tissue • Unpredictable association between infection and renal scarring • Early antimicrobial treatment decreases scarring
  • 59. Chronic Pyelonephritis • Associated with reflux nephropathy – Scarring associated with reflux of infected urine – No scarring with reflux of sterile urine • 55 Adults with reflux nephropathy – UTI diagnostic event in 80% – 20% with enuresis – 50% with elevated serum creatinine – 38% had hypertension – 35% had proteinuria
  • 60. Chronic Pyelonephritis - Diagnosis • Often discovered incidentally • Azotemia, hypertension, fatigue • UA: WBC, proteinuria • Decreased ability to concentrate urine
  • 61. Chronic Pyelonephritis • IVU – Small, atrophic kidney – Scarring with calyx clubbing • VCUG in children
  • 62. Renal Abscess - Etiology • Majority are secondary to ascending gram-negative infection – Associated tubular obstruction (due to prior infection or calculi) • Skin carbuncles or IVDU may lead to gram-positive abscess formation • Complicated UTI with associated stasis due to calculi or neurogenic bladder.
  • 63. Renal Abscess – Clinical Sx / Labs • Symptom: – Fever , chill , pain – weight loss, malaise • Lab: Marked leukocytosis • UA may be normal, unless there is communication between abscess and collecting system
  • 64. Renal Abscess – Radiologic findings • CT of early abscess: – Renal enlargement • CT of late abscess: – Fibrotic wall – Obliteration of adjacent tissue planes – Ring-enhancing • U/S shows hypoechoic mass
  • 65. Renal Abscess - Treatment < 3 cm: IV ABx & observation - Serial exam with U/S or CT until resolution 3-5 cm: Percutaneously drain >5 cm: Surgical I&D
  • 66. Pyonephrosis Infected hydronephrosis associated with suppurative destruction of the kidney parenchyma & in which there is total or nearly total loss of renal function.
  • 67. Pyonephrosis - Diagnosis • F/C/Pain • Lack of bacteriuria indicates complete ureteral obstruction • Urographic findings – obstruction • Infected hydronephrosis always shows good ultrasonic transmission; pyonephrosis shows persistent echoes or a fluid-debris level
  • 68. Pyonephrosis - Treatment • Antimicrobial drugs • Drainage of the infected pelvis (ureteral cath or perc drain) • Identify & treat source of infection after patient becomes hemodynamically stable
  • 69. Perinephric Abscess • Located within Gerota’s fascia • 56% mortality rate – Delay in Dx (misdiagnosed as acute pyelo) • Due to hematogenous seeding or from renal extension of ascending UTI – Use of antimicrobial therapy has decreased the chance of hematogenous seeding from wound and skin infections.
  • 70. Perinephric Abscess - Diagnosis • No pathognomonic abnormalities on any radiologic examination. • Decreased renal mobility is the most specific finding – (Insp/Expir films). • U/S or CT Scan – Dx &/or Treat • Treatment: Drainage (surgical vs. perc)
  • 71. Perinephric Abscess vs. Acute Pyelo • >5 days of symptoms prior to hospitalization • Fevers persist beyond 4 days • <5 days of symptoms prior to hospitalization • No fevers beyond 4 days after appropriate antibiotics started
  • 73. What are the definitions of infection?
  • 74. What is Systemic inflammatory response syndrome (SIRS) ? • Response to infection (sepsis) or non-infection (burn, pancreatitis) • 2 of the criteria require
  • 75. What is the pathogenesis of sepsis? • Endotoxin release by G-ve bacteria • Trigger release of mediators, like cytokine, activation of kinin system, complement system and fibrinolytic system • Activation of white cell and macrophages • Widespread microvascular injury, tissue ischemia & clinical manifestation
  • 76. Pt is very unwell , what to do? • ICU • Consideration of vasopressor, inotropes, steriod • Radiological investigation to identified source and complication
  • 78. Case • F/40 • Good PH • HPI: – Acute left loin pain – Low grade fever – Vomiting (secondary to paralytic ileus) • PE: – BP 120/60, p 110, temp 37.8 – Abd soft, left loin mild tenderness, no mass, • KUB: no stone • Urine stix: nitrate+, WBC+, RBC + • Bedside USG: no hydronephrosis/stone • CBC: WCC 14, Hb 12 • RFT Cr 100, CaPO4, urate normal
  • 79. Case • Imp: Acute pyelonephritis • IV zinacef • Progress – Low grade fever and tachycardia – Left loin pain slightly improved – Not septic looking • DDx? • Ix?
  • 80. KUB
  • 81. CT
  • 82. EPN causes and pathogenesis • Acute necrotizing infection of the renal parenchyma and its surrounding tissues by gas forming organism • Presence of gas in the renal parenchyma, collecting system or perinephric tissue • Most common: Escherichia coli in 70% and Klebsiella • Others: – Proteus mirabilis, Group D Steptococcus and CNS – Anaerobic and rare: Clostridium septicum, Candida albicans, Cryptococcus neoformans and Pneumocystis jiroveci • Bacteriaemia: found in 50% EPN, same species as urine/pus • Severe, acute pyelo that fails to improve during the initial 3 days of treatment
  • 83. EPN pathogenesis • Female: Male = 6:1 • Factors – High glucose level (DM) – Gas-forming microbes – Impaired vascular blood supply – Reduced host immunity – Urinary tract obstruction (stone) • Mechanism – G-ve facultative anaerobes e.g. E coli produce gas via fermentation of glucose  high levels of nitrogen, oxygen, CO2 and H2 accumulating at inflammatory site  gas may extended the inflammatory site to subcapsular, perinephric and pararenal spaces
  • 84. EPN histopathology • Abscess formation • Foci of micro and macro-infarction • Vascular thrombosis • Numerous gas-filled spaces • Area of necrosis surrounded by acute and chronic inflammatory cells implying septic infarction
  • 85. EPN presentation • Age: 40-50 • S/s = pyelonephritis – dysuria, fever/rigors, nause, vomiting, flank pain • Impaired consciousness • Septic shock • PE: – Loin tenderness (most common) – Crepitus around renal area or scrotum • NOT respond to pyelonephritis Tx • Ix: – Leucocytosis (70-80% reported case) – Thrombocytopenia (15-20%) – Acute renal dysfunction – Acid-base disturbance – Hyperglycaemia – Microscopic / gross haematuria – Severe proteinuria
  • 86. EPN diagnosis • Radiological Dx – Gold standard: CT • CT: more sensitive and define extent of EPN by identifying features of parenchymal destruction • USG accuracy 69%, KUB 65% – KUB: abnormal gas shadow in renal bed
  • 87. EPN classification • Base on CT feature • Wan: used in 2 meta-analysis, prognostic value, type 1 > 60% mortality, type2 > 20% mortality • Huang and Tseng: for Mx • One classification proposed by Wan et al – Type I : parenchymal destruction with either an absence of fluid collection or presence of streaky or mottled gas (mortality 60%) – Type II : renal or perinephric fluid collection with bubbly or located gas or gas in the collecting system (mortality 20%)
  • 88.
  • 89. EPN prognostic factors • Falagas et al J Uro 2007 • Poor PF: 1. SBP <90 2. Impaired consciousness 3. Increase serum Cr 4. Thrombocytopenia 5. Bil EPN 6. Medical Mx with Abx alone 7. Wan’s Type I (air only, no fluid) • Factors NOT increased mortality – DM – Stone – E. coli – K. pneumaiae – Age >50 – Female – Hx of UTI – Alcoholism
  • 90. EPN management • High index of suspicion in pt fail medical treatment for acute pyelonephritis • Active resuscitation • Medical Mx (MM) – O2, IVF, Acid base balance, Abx, good glycaemic control – Keep SBP >100 with IVF +/- inotropes – Empirical Abx: AG, b-lactamase inhibitor, CS, quinolones, till c/st a/v – Renal support if ARF – ICU care if multiorgan support need
  • 91. EPN Management • Percutaneous drainage PCD + MM – 1st shown in Hudson et al. J Urol 1986 – Meta-analysis (Somani BK et al. J Urol 2008): • PCD + MM as most successful Mx (30-100%) with lowest mortality 13.5%, subsequent nephrectomy mortality 6.6% – Significant reduction in mortality (nephrectomy mortality 40-50%) – Preserve function of affected kidney in ~70% cases – For pt with localized areas of gas + functioning renal tissue – Multiple catheters for loculated/multiple abscess – Tube can be flushed with Abx solutions
  • 92. EPN: PCD + MM • Huang and Tseng classification – Class 1 (gas in collecting system only): PCD + MM – Class 2 (parenchymal gas only): PCD +MM – Class 3 (3A peripheric gas, 3B pararenal gas): • Depend on risk factors: – diabetes, thrombocytopenia, acute renal failure, altered level of consciousness, shock • 0-1 risk factor: PCD+MM survival rate 85% • >=2 risk factors: failure 90%  nephrectomy – Class 4 (soliatory kidney/Bil EPN): • PCD + MM – If failed to respond: Nephrectomy + ICU + renal support
  • 93. Huang and Tseng classification Class 1 Pelvicalyceal gas only Class 2 Parenchymal gas only Class 3A Perinephric gas Class 3B Pararenal gas Class 4 Solitary kidney/Bil EPN Risk factors: 1.DM 2.PLT 3.ARF 4.GCS 5.Shock
  • 95. Q68
  • 96. • KUB and CT scan of a patient with vague R flank pain and ballottable mass • What is the diagnosis? (3) • Under microscopy, what is a characteristic feature in this condition? (2)
  • 97. • KUB : multiple renal stones in R kidney • CT : classic “bear’s paw” appearance, lower cut showing stones inside dilated calyces • Dx : Right xanthogranulomatous pyelonephritis (3) • Lipid-laden macrophages (Xanthoma cells) (2)
  • 98. XanthogranulomatousXanthogranulomatous PyelonephritisPyelonephritis • Chronic renal infection that results in local or diffuse (2 types) renal destruction. • Almost all cases are unilateral • A nonfunctioning, enlarged kidney associated with obstructive uropathy secondary to nephrolithiasis • Female in their 5th to 7th decade • 75% have positive urine cultures and 90% have positive tissue culture • The commonest organisms isolated are Proteus or E.coli • 83% of patients have associated nephrolithiasis • 50% such stones are of staghorn stones
  • 99. Xanthogranulomatous PyelonephritisXanthogranulomatous Pyelonephritis • Presentation: 70% flank pain, 70% fever/chills, 60% flank mass • Histologically – Accumulation of lipid-laden foamy macrophages (xanthoma cells) – Inflammatory process begins within the pelvis and calyces & subsequently extends into and destroys renal parenchymal and adjacent tissues. – Can be confused with RCC even on frozen section • Treatment : – if malignancy suspected / kidney diffusely destroyed – open nephrectomy – very stuck and high risk of vessels and visceral injury • Imaging triad (seen in 50-80%) : – Unilateral renal enlargement – no / poor function – A large calculus in the renal pelvis • Classic “Bear’s paw sign” on CT
  • 101. How to diagnosis urinary TB?How to diagnosis urinary TB? • Presentation: – Previous TB exposure – Loss of appetite – Fever, night sweat – Loin pain , hematuria and suprapubic pain • Physical examination: – Temp , LN – Chest , abdomen , genital (bead like cord) • Bld , EMU, CXR, KUB, USG + RU
  • 102. • EMU – more concentrated as TB is secreted intermittently 1. Ziehl-Neelsen stain to look for acid fast bacilli 1. Bacterial smear is stained with carbol fuchsin for 2 minutes, then decolorised with HCL and ethanol which then restained with crystal violet  view under oil immersion 2. Acid-fast bacilli  pink, non acid fast bacilli  purple 3. Not suitable for gram stain as high lipid content of cell wall 2. Lowenstein-Jensen is an egg based solid culture medium used to identify TB 3. Culture in a liquid medium takes 2-3 days whereas in a solid medium takes 6-8 weeks 4. PCR to amplify the specific DNA by in-vitro enzymatic replication • Pathogensis – caseating granuloma (Langhan’s giant cells surrounded by lymphocytes and fibroblast)  fibrosis + calcification  autonephrectomy • TB epididymis is likely from hematogenous spread as it is usually isolated finding
  • 103. How to diagnosis urinary TB?How to diagnosis urinary TB? • Tuberculin: purified protein deverivative to prove TB status. – Positive  confirmed exposure to TB – Negative  exclude the diagnosis • CXR: lung primary focus in 50% of cases with urogenital TB • KUB shows calcification in 50% of cases • CT or IVU is abnormal in 60-90% of cases 1. Small shrunken kidneys (autonephrectomy) 2. Infundibular stricture (pathognomonic) 3. Calyceal distortion + calcification 4. Papillary necorisis 5. Multiple ureteric stricture : commonly at lower third of ureter 6. Distortion of ureteric orifice – VUR (Golf-Hole app) 7. Contracted calcified bladder: Bullous edema , ulcearation and hemorrhage (Thimble bladder) 8. Calcified vas (beaded), seminal vesicle or prostate
  • 104. What is the treatment of TB? • Isoniazid, rifampicin, ethambutol and pyrazinamide for 2 months • Isoniazid and rifampicin for 4 months • Steroid for ureteric stricture that do not respond to anti-TB drugs • Cycloserine is used to inhibit the growth of BCG sepsis within 24 hours – But if will lower seizure threshoid
  • 105. What is the complication of the drugs?
  • 107. Acute bacterial prostatitis • Infection of the prostate asso with LUT infection & generalized sepsis • Risk factor: – UTI – Acute epididymitis – Catheter , post TURP – Intraprostatic ductal relfux – Phimosis – Prostate stone • Presentation: – Systemic illness – Preineal and SP pain – Irritative LUTS – AROU – Prostate is exteremely tender
  • 108. • Investigation: – Bld + c/st – MSU • Txn: – Antibiotic: Cirpo 500mg BD for 2-4 week – Pain relief – Catheter – Prostate abscess: dx by TRUS or CT – Drainage: percutaneous or TUR
  • 109. Men present with recurrent UTI • History: – Associate LUTS – Stone disease – Diverticulum +/- fistula: pneumaturia, recurrent diarrhoea , rectal bleeding , fecaluria – Chronic prostatitis : Dysuria, hematuria, Perineal/suprapubic discomfort, Ejaculatory problems • PE: – Abd + kidney – Suprapubic region – External genitalia and prostate • Investigation: – MSU – KUB – USG – FR + RU – Specific test : Stemey + NIH-CPSI
  • 110. UTI in men • Men should receive, as minimum therapy, a 7-day antibiotic regimen • Minimum treatment duration of 2 weeks is recommended, preferably with a fluoroquinolone if prostatic involvement • Prophylactic antibiotics reduce the risk of bacteriuria and septicemia by 70% and 80% respectively after TURP – Berry: Prophylactic antibiotics in TURP J Urol 2002
  • 111. Prostatitis • Definition: Infection or inflammation of prostate • Chronic prostatitis: – Clinical syndrome characterize by pain in perineum, pelvis, suprapubic area or external genitalia – Variable degree of voiding or ejaculatory disturbance • Dx of exclusion : to rule out BPH , stricture, UTI • Pathophysiology poorly understood: 1. Infection 2. Chemical irritation 3. Dysfunctional high-pressure voiding 4. Intraductal reflux 5. Altered immunity – Proposed inflammatory process cause tissue edema & intraprostatic pressure  local hypoxia  mediator induced tissue damage altered neurotransmission in sensory nerve  pain and other symptom
  • 112. What is the definition ofWhat is the definition of prostatitis?prostatitis? >10 WBC /HPF Prostadynia – pain without positive culture or inflammatory component
  • 113. What is stamey test?What is stamey test?
  • 114. Meares and Stamey • Drink 400ml of water 30min before the test • 4 sterile specimen container: VB1, VB2, EPS, VB3 • Expose glans penis and retract foreskin • Cleanse the glans with soap • 1st 10-15ml urine: VB1 • Pass next 100-200ml into toliet • 2nd 10-15ml urine: VB2 • Patient bend forward & hold container marked EPS near urethral meatus • Massage prostate until few drops of prostatic secretion are collected : EPS • Void and collect the 10-15ml urine: VB3
  • 115. Interpretation of Stamey test • +ve VB1: Urethritis • +ve VB2: Cystitis • Chronic prostatitis – II: +ve c/st in EPS & VB3 – IIIa: -ve c/st in EPS & VB3, +ve WBC – IIIb : -ve c/st in EPS & VB3 , -ve WBC • Modification of Stamey test: – Pre & post-message test (PPMT) [Nickel] – +ve post-message c/st  chronic prostatitis
  • 116. ProstatitisProstatitis • NIH – CPSI (National Institutes of Health- Chronic Prostatitis Sympotm Index) – Measure the severity of chronic prostatitis – 9 item questionnaire with 3 main domains (pain, urinary symptoms and QOL) – Pain (location, frequency , severity) – Voiding (obstructive and irritative) – QOL – For assess need of treatment and monitor response • MTOPS study suggests that prostatitis may be a predictor of BPH progression • Nickel and coworker report a 2% incidence of bladder CIS in patients with clinical prostatitis and they therefore recommend urine cytology when investigating men with suspected prostatitis
  • 117. Management • According to predominant symptom & QOL • Discuss about benign nature of the condition • Lock of evidence in favour of any treatment • Goal should be symptom control rather than eradication • Conner stone: – Antibiotic – Anti-inflammatory – Alpha-blockers
  • 118. Chronic bacterial prostatitis RxChronic bacterial prostatitis Rx • NSAID/Antibiotics at least 6 weeks - empirical treatment suggested by European consensus group • E Coli positive in prostate massage in asymptomatic patient should be treated • Quinolone and tetracycline – good penetration • Moxifoxacin – good in G+ve • Macrolide – good for chlamydia • Tetracyclin for sub-clinical infection : Chlamydia & ureaplasma • Nitrofurantoin and penicillin – poor penetration • Add alpha blocker for 3m if no response by 6week • Finasteride can cause a 50% improvement in the symptoms of about 50% of patients with type 3 prostititis • Muscle relaxant – diazepam or baclofen • Tricyclic antidepressant: Amitriptyline • Prostatic message if not responsive – Expression of prostatic secretion, relief of pelvic muscle spasm, physical disruption of protective biofilm and improve circulation – Some symptomatic relief in ~1/4 to 1/3 patients
  • 120. Scrotal pain and fever • Ddx: Trauma , testicular torsion , epididymo-orchitis • History – Trauma – < 35 yo STD: Chlamydial or gonococcal – In old: UTI cause by E coli – UTI : dysuria, frequency , urgency , SP pain – Systemic illness – Long term use of amiodarone (chemical epididymitis) • P/E: – Cannot diff from torsion – Scrotal pain radiate to groin – Erythema or scrotal skin – Thickening of spermatic cord, reactive hydrocele – Urethral discharge – Elevation of scrotum relieved pain in epididymo-orchitis (Prehn’s sign)
  • 121. • Investigation: – MSU – Gram staining and C/st of urethral swab (Gram –ve intracellular diplococci) – Chlamydia: detect DNA by PCR on first void urine – Basic blood test • Treatment: – Bed rest, scrotal suppor – Analgesic – Antibiotic: Cipro 500mg BD (cover gonococccal) + Doxycycline 100mg BD (cover Chlamydia) x 2 weeks – If allergic to doxycycline  azithromycin 1g x1 – If elderly  likely E coli : Ciprofloxacin only – Order USG if not resolved (abscess) – FR + RU exclude underlying LUTS • Complication: – Abscess, infarction , chronic pain , infertility • Mumps orchitis: 30% post-pubertal male, 3 day after parotitis, 30% bilateral , result in testicular atrophy and infertility
  • 123. What is the biofilm?What is the biofilm? • Complex aggregation of organisms on solid substrate, protected by extracellular mucopolysaccharide matrix in an aqueous environment • Or , structured community of micro- organisms and their extracellular products form on the surface of any biomaterial
  • 124. UTI in pregnancyUTI in pregnancy
  • 125. Anatomic & Physiologic Changes • 1cm increase in renal length • Smooth muscle atony of collecting system – Progesterone & Uterus size • Bladder displaced superior & anterior • 30-50% increase in GFR – Evaluate renal Fx if Cr >0.8 or BUN >13 – Normal to have proteinuria up to 300mg/24 hours
  • 126. UTI • Incidence of male UTI - 1% • Incidence of female UTI – 5% • Incidence of female UTI after menopause – 20% • High fluid intake/voiding every 4 hrs/ post-coital voiding/perineal hygiene • -ve urine c/st to confirm eradication of bacteria
  • 127. Asymptomatic Bacteriauria • All women should be screen at week16 • Definition: – Asymptomatic + 10 5 (CFU) of a single pathogen / ml of urine – But 102 CFU can also be counted as significant • Asymptomatic bacteriuria in pregnancy – ~5% • Risk of acute pyelonephritis: in 3rd trimester – 1-4% in all pregnant women – 20-40% in untreated bacteriuria • Treatment is necessary  1% if treated
  • 128. • 3-day course of therapy • Reculture urine 1-2 days after treatment • Use parenteral agents to treat acute pyelonephritis
  • 129. Antibiotics Safe: • Penicillin: OK • Cephalosporin: OK • Marcolide - Erythromycin (bacteriostatic): OK Use with cautions: • Nitrofurantoin: avoid in third trimester – Fetal hemolytic anemia in G6PD deficiency mother – hepatotoxicity, lung toxicity, inadequate urine concentration if GFR<60 • Aminoglycoside (bacteriostatic): CI in 2nd and 3rd trimesters – can cross placental barrier: fetal ototoxicity & nephrotoxicity – Used only for short periods for severe acute pyelonephritis threatening materal-fetal prognosis • Sulphonamide : contraindicated in third trimester – Risk of neual tube defect in 1st trimester due to anti-folate mechanism – Risk of fetal anemia in G6PD def mother • Triamethoprim : contraindicated in first trimester
  • 130. Contraindicated: • Fluoroquinolone (bacteriostatic): contraindicated as toxicity to fetal cartilage and joints, tendon damage • Chloramphenicol: contraindicated in third trimester as “grey-baby” syndrome • Tetracycline (bacteriostatic): contraindicated as hepatotoxicity, deposit in teeth and bone • Recurrent UTI in pregnancy – cephalexin 125mg daily
  • 131.
  • 132.
  • 133.
  • 134. Acute pyelonephritis • USG findings: focal or diffuse hyperechogenicity, thickening of renal pelvis and ureteral dilation • Higher risk if asymptomatic bacteriuria / VUR (correction of VUR cannot prevent UTI during pregnandy) / history of renal scarring • Complications associated with bacteria during pregnancy – Prematurity, low birth weight, prenatal mortality – Maternal anemia • Hospitalization and parental antibiotics
  • 135. Pregnancy and VUR • Higher chance of pyelonephritis if previous VUR or history of renal scarring • History of renal scarring – Higher chance of HT (3.3 fold) – Pre-eclampsia (7.6 fold) – Obstetric intervention • Higher chance of pre-eclampsia if bilateral scarring or impaired creatinine level • Despite previous reimplantation in childhood, still higher risk of UTI, but not miscarrage
  • 136. (Spontaneous renal rupture) • No cause vs upper tract obstruction vs tumour like AML • Lumbar or abdominal pain / shock • US : retroperitoneal hematoma • JJ / PCN if obstruction • Unstable hemodynamically: nephrectomy
  • 137. Before having babies… • Consider stone treatment before pregnancy • Consider AML treatment
  • 139. How to use gentamicin? • Bactericidal – inhibit ribosomal protein synthesis • 3-7mg/Kg • Check level after the 3rd dose • <1mg/l  give the same dose • 1-2mg/l  reduce the dose by 25% and check the level before next dose • 2mg/l  omit one dose and check the level • Bad with Frusemide (increase nehrotoxicity) • Good for pseudomonas, enterococcus and staphylococcus • Daily dose is usually used • Can be used in patient with renal impairment with dose modification • Ototoxicity cause more commonly vestibular damage than deafness, 2/3 patients present as tinnitus • Nephrotoxicity and impaired neuromuscular transmission
  • 140. UTI in renalUTI in renal impairmentimpairment
  • 141. What is the antibiotic in renal impairment?
  • 143. • Up to 25% of hospitalized patients undergo urinary catheterization. • indwelling urinary catheters are a leading cause of nosocomial infection and have been associated with both morbidity and mortality. • Up to 30% of catheterized patients can have genitourinary or systemic symptoms related to catheter-associated UTI (CAUTI) • Up to 4% may develop catheter-related bacteraemia • Once the catheter has been removed some patients with asymptomatic CAUTI continue to have bacteriuria or become symptomatic • To prevent or reduce this type of catheter-related morbidity, many clinicians have a policy of administering a short course of prophylactic antibiotics on catheter withdrawal for all or selected groups of patients. • Currently, the most appropriate agents for the empirical management of CAUTIs seem to be co-amoxiclav, ciprofloxacin and nitrofurantoin.
  • 144. What is the recommendation of catheter insertion and choice of catheter?
  • 145. How to prevent catheter related UTI?
  • 146. What is the treatment of catheter related UTI?
  • 149. Spinal cord injury patients • 33% have bacteriuria • UTI is the most common urologic complication & the most common cause of fever in these patients • Risk factors: – Bladder overdistention – Elevated intravesical pressure – VUR – Impaired voiding – Instrumentation
  • 150. Clinical presentation & Bacteriology • Majority are asymptomatic • Symptoms: – Abdominal discomfort – Urinary leakage – Lethargy / Malaise – Cloudy, malodorous urine • E. coli isolated in only ~20% • Enterococci, P. mirabilis, Pseudomonas
  • 151. Management • SP cath delay onset of bacteriuria, when compared with indwelling urethral cath • CIC allows for lowest risk of complications • Urine culture prior to therapy • Oral fluoroquinolone is 1st line
  • 152. Emphysematous cystitis • Necklace appearance of gas beads in bladder wall diagnostic of emphysematous cystitis • due to infection by gas forming organisms (commonest E Coli) in an immunocompromised patient (usually DM)
  • 154. EC • DDx: – Instrumentation – Fistula to hollow viscus – Tissue infarct with necrosis – Infection • EC more common in – Middle aged diabetic women (M: F = 1:6) • Predisposing factors – DM (66%), Chronic UTI, indwelling urethral catheter, urinary stasis due to BOO, neurogenic bladder • Various s/s – Asymptomatic, pneumaturia, irritative voiding, acute abdomen to severe sepsis • Pathogens: – E. coli (58%) – Others: K. pneumoniae, P. aeruginosa, Proteus mirabilis, Candida albicans and C. tropicalis, Aspergillus fumigatus, Staphylococcus aureus, Group D Streptococcus, Enterococcus faecalis, Enterobacter aerogenes and Clostridium perfringens and Cl. welchii. • Pathogenesis: – like EPN, – non-diabietic: urinary albumin as substrate
  • 155. EC • Radiological Dx – KUB: curvilinear area of radiolucency delineating the bladder wall with or without intraluminal air – CT: more sensitive, define extent and severity, differentiate vesicoenteric fistula, intraabdominal abscess, adjacent neoplastic disease, EPN • Histopathology – Gross: • Bladder wall thickening with vesicles of varying size – Microscopic: • multiple gas-filled vesicles predominantly within the bladder mucosa, lined by flattened fibrocytes and multinucleated giant cells
  • 156. EC management • MM: – Abx, bladder drainage, DM control, correct underlying comorbidities • If fail to respond/severe necrotizing infection (10%) – Consider partial cystectomy, cystectomy or surgical debridement – EC alone Mortality 7% – EC + EPN Mortality 14%
  • 158. What is endotoxin?What is endotoxin? • Lipopolysaccharide complex related to the outer membrane of gram negative bacteria • Gram negative sepsis • Their lipid component is the toxic one (Lipid A) and the polysaccharide element is the immunogenic one (O-antigen) • Endotoxins are heat stable to boiling point
  • 160. What is papillary necrosis?What is papillary necrosis? • Possible causes of papillary necrosis is POSTCARD • Pyelonephritis, Obstruction. Sickle cell, Tuberculosis, Cirrhosis, Analgesic, Renal vein thrombosis, Diabetes
  • 162. Viral disease of the genital tract
  • 163.  Painful ulcer  Diagnosis? (1) Chancroid  Causative agent? (1) Haemophilus ducreyi Q3
  • 164. ChancroidChancroid • Presentation: painful nonindurated ulcer + tender unilateral inguinal adenopathy • Characteristic suppurative inguinal adenopathy • Haemophilus ducreyi : – fastidious (difficult to culture) – short, fine, gram-negative streptobacilli – FDA approved: PCR assays • Treatment: – Ciprofloxacin, (500 mg orally BD for 3 days) – Erythromycin , (500 mg orally TID for 7 days) – Azithromycin, (1 g as a single oral dose ) – Ceftriaxone, (250 mg as a single intramuscular dose ) – Tetracycline
  • 165. Male 30 with painless ulcer over coronal sulcus
  • 166. Genital • What is the diagnosis? – Chancre, ulcer typically painless, indurated and with raised border. Regional lymphadenopathy appear in one week. • What is the causative agent? – Treponema pallidum (spirochetes), confirmed by dark field examination • What is the treatment? – Penicillin – good prognosis if treated. If not treated > neurosyphillis/dementia/gumma
  • 167. Male 25 with lesion over glans. Biopsy done.
  • 168. Genital • What is the diagnosis? – Condyloma acuminatum • What is the causative agent? – Human papillomavirus types 6,11. – Dysplastic types are caused by type 16, 18. (premalignant) • What is the treatment? – Podophyllin, cautery after biopsy or surgical excision or CO2 laser
  • 170. 25 year old man with ulcer over glans.
  • 171. Genital • What is the diagnosis? – Granuloma inguinale - Irregular painful ulcer with purulent base. No inguinal lymphadenopathy, but subcutaneous granulomatous process – Dx: identification of “Donovan Body” on stained smear • What is the cause? – Calymmatobacterium granulomatis • What is the treatment? – Tetracycline/ampicillin , septrin or erythromycin
  • 172. 25 year old man with painful lesions over penile skin
  • 173. Genital • What is the diagnosis? – Genital herpes. • What is the cause? – Usually herpes simplex virus type 2 infection • What is the treatment? – Acyclovir, long term suppression may be required if recurrence. Prevent transmission with barrier contraception
  • 174. Male 25, itchy lesion over penile skin. Biopsy done
  • 175. Genital • What is the diagnosis? – Molluscum contagiosum – small papules, may express cheesy-like material • What are the diagnostic features on histology exam? – Molluscum bodies in cells (Basophilic inclusion filled with the virus) in biopsy • What is the cause? – Viral infection by poxvirus, transmitted by sexual contact • What is the treatment? – Self limited. Healed without scars. Podophyllin or cauterisation
  • 177. Schitosomiasis (Biharzia) • Cause: trematode called Schitosoma haematobium • Endemic : Africa , Egypt, middle east • Pathology : – Fresh water snails release infective form of the parasite (cercariae) – Penetrate skin and migrate to live (schitosomules) where they mature – Adult form migrate to vesical vein – Lay egg (containing miracidian larvae)  leave body by pentrating the bladder and enter urine
  • 178. • 2 phase: – Active: where adult worm laying eggs – Inactive: when adult die and reaction to remaining egg • Clinical presentation: 1. “Swimmer’s itch” : local inflammation by cercarial penetration (24hr) 2. Katayama fever (acute schistosomiasis): • Egg lying : induce fever, urticaria, LN, Hepatosplenomegaly 3. Acute inflammation phase: egg penetrate & excreted in urine : hematuria, frequency and terminal dysuria 4. Chronic active phase: • Low egg laying • Nephritic syndrome by deposition of IG complex in glomeruli 5. Chronic inactive phase: no viable egg • Symptom of obstructive uropathy
  • 179. Diagnosis + MxDiagnosis + Mx Diagnosis: 1. Midday urine: continue egg 2. Bladder and rectal biopsy : identify egg 3. Serology test: ELISA 4. Cystoscopy: identifies egg in trigone (Sandy Patches) 5. CT or IVU: calcified , contracted bladder with obstrucitve uropathy 6. USS: hydronephrosis and thicken bladder wall Treatment is pharmacological with praziquental • 20 mg/kg in 2 divided does 4-6 hours apart on the same day • Single dose of praziquental may be effective • Praziquental is effective against all species of schistosoma and all stages of the disease. It will cure 85-100% of cases. When it fails to cure the disease a second course of praziquental could be tried • Complications - Bladder contracture, ureteric obstruction, squamous cell ca bladder
  • 180. These are the eggs of 3 species of Schistosoma  Which of the above species is related to bladder cancer? (1)  In what form does this species infect human in water? (1) A B C
  • 181. • A : Schistosoma japonicum • B : Schistosoma haematobium • C : Schistosoma mansoni • B (1) • Cercariae (1) – The flatworm cercaria is found in river water and will penetrate unbroken human skin, typically through the web between toes, to enter the peripheral systemic vein – The eggs will penetrate through the bladder wall and will be found in the urine
  • 182. Urinary schistosomiasisUrinary schistosomiasis • Urinary schistosomiasis is most commonly caused by schistosoma hematobium. This is endemic in Africa and middle east. It produces the characteristic end spined eggs but this is not the only species with end spined eggs • Schistosoma japonicum is endemic in the far east • Schistosoma Mansoni in Latin America
  • 183.  What is the diagnosis? (1)  What is the acute phase of this disease called? (2)
  • 184. • Characteristic egg-shell calcification outlining urinary bladder • Dx : Schistosomiasis (1), DDX: TB • Katayama fever (2) – Coincides with egg laying – Active phase is characterized by urinary symptoms such as hematuria and terminal dysuria. Cystoscopically there may be inflammatory polypoid lesions in the bladder and eggs in the urine – The chronic inactive phase,although asymptomatic, will slowly progress into obstructive uropathy and may be complicated by bladder cancer
  • 186. Hydatid diseaseHydatid disease • Also known as echinococcus, is a tapeworm parasite infection • The intermediate host is the sheep and the final host is the dog. • Kidneys can be affected in about 5% of cases • The disease is bilateral in 6% of cases • In the kidney the upper and lower poles of the kidneys are more commonly affected (80%) than the midpole of the kidney • The renal cysts are not symptomatic until late in the disease • Common symptoms are flank pain (80%) and flank mass (40-75%) • USG and CT scans show thick wall multiloculated cysts • KUB shows calcifications in 30% of cases • Bld: peripheral eosinophilia & +ve hydatid complement fixation test • Medical: Albendazole • The mainstay of treatment is surgical excision of he cysts with 1st sterilized with formalin or alcohol
  • 187. • Diagnosis ? (1) Q11
  • 188. • Angiokeratoma of Fordyce (1) • No malignant potential (1)
  • 189. Angiokeratoma of Fordyce • Vascular ectasias of dermal blood vessels • Visible on the penis and scrotum of adult men • 1- to 2-mm red or purple papules with associated generalized scrotal redness • Benign condition without systemic manifestations • Rare cause of troublesome scrotal bleeding Can be seen in patients with Fabry's disease : rare glycogen storage deficiency • Treatment : – Usually unnecessary – Success achieved using YAG, KTP/ argon laser photocoagulation in select cases
  • 190. Physical findings of a sexually inactive 20-yr-old male  Diagnosis ? (2)  Is it associated with HPV infection? (1)
  • 191. • Pearly penile papules (PPP) (2) • No relationship with HPV. Benign lesion (1)
  • 192. PPP • White, dome-shaped, closely spaced small papules at glans penis • Arranged circumferentially at corona • Histology : angiofibromas similar to lesion TS • 14-48% of young adults (uncircumcised) • NO association with HPV infection/ cervical CIN • Mx: Reassurance • Local destruction: CO2 laser, cryotherapy
  • 193.  These ulcers in a sexually-inactive 20-yr-old man are painful and recurrent.  Diagnosis ? (3) Q29
  • 194. • Pictures showing multiple scrotal, perianal ulcers as well as oral aphthous ulcers • Behçet’s disease (3)
  • 195. Behçet’s disease • Classified as a form of vasculitis • Initially found along Silk Road, now found everywhere in the world • No gender difference in epidemiology, mean age of onset ~30yrs • Clinical manifestation: – Mucous membrane manifestation • Oral aphthosis (nearly in every patient) • Genital aphthosis (60-100% of patients) : Scrotal and vulval ulceration, sometimes on shafts of penis – Skin manifestation • Skin aphthosis / pustulosis • Pathergy phenomenon (skin hypersensitivity to trauma, considered a diagnostic test) – Ocular manifestation • Anterior and posterior uveitis, retinal vasculitis – Arthritis, Meningoencephalitis, Vascular involvement (DVT), gastrointestinal aphthosis • Diagnostic criteria: International Criteria for Behçet’s disease (ICBD) • Genetic background: HLA-B51 may be associated • Treatment: Colchicine 1mg daily is 1st line
  • 196.  This is the result of a chronic infective process  Name three possible micro-organisms responsible. (3)  Name one vector of transmission of the above micro- organisms (1) Q30
  • 197. • Picture showing penoscrotal elephantiasis 1. Wucheraria Bancrofti (1) 2. Brugia Malayi (1) 3. Onchocerca volvulus (1) 4. Vectors • (W. bancrofit, B. malayi) Mosquito eg. Culex spp • (O. volvulus) Black fly of Simulium spp • Dx: Thick film , serology or biopsy • Presentation: – Funiculoepididymitits, orchititis – Hydrocele – Scroal and penile elephantitis • Treatment: – Medical: Diethylcarbamazine – Surgerical excision of fibrotic & edematous tissue
  • 198. This is an STD  What is the diagnosis? (1)  What is the causative organism? (1)  Name two other diseases this organism is responsible for (0.5 each) Q47
  • 199. • Lymphogranuloma venereum (LGV) (1) • Chlamydia trachomatis (serotype L1, L2, L3) (1) 1. Trachoma (serotype A, B, Ba, C) (0.5) 2. Non-gonococcal urethritis (serotype D to K) (0.5)
  • 200. Lymphogranuloma VenereumLymphogranuloma Venereum • STD caused by Chlamydia trachomatis types L1, L2 & L3 • Transient painless ulcer on the penis, anus or vulvovaginal area that goes unnoticed  painful unilateral suppurative inguinal adenopathy and constitutional symptoms that occur 2-6wks after resolution of the ulcer • Groove sign: large inguinal and femoral LN separated by inguinal ligament. Secondary LN lesions in lymphogranuloma venereum • Mainly clinical diagnosis • Culture positive <50% cases • Can be diagnosed using antibody titre • Tx: Doxycycline 100mg BD or erythromycin 500mg QID for three weeks at least
  • 201. Photo • This elderly woman complained of severe symptoms of cystitis of sudden onset.
  • 202.
  • 203. Q • A. What abnormality is shown? – herpes zoster (1/2) • B. What are the typical cystoscopic appearances? – hemitrigonal vesicles (1/2)
  • 204. Q. CT • These are CT and ultrasound scans of a 74 year old man with urinary retention and fever of 38.6
  • 205. Q • A. What is the diagnosis? – prostatic abscess (1) • B. How should his retention be managed? – suprapubic catheterisation and drainage of abscess (1)
  • 206. Antibiotic prophylaxis in urology • Brief course of antibiotic administer before or at the start of an intervention • To minimize the infectious complications of the procedure • Possible side effect & microbial resistance patterns are potential risk
  • 207. • Yes with high level of evidence: – TURP (decrease bacteriuria & infectious complication) – Prostate biopsy (reduce bacteriuria but no conclusive evidence on reducing symptomatic UTI or other infectious complication) • Yes with moderate to low evidence: – Cystoscopy (not require in the absence of risk factor) – Therapeutic URS – Open /lap uro intervention (clean-contaminated & contaminated) • Not required in: – Urodynamic study (except with increase risk e.g neurogenic bladder, transplant patient, immunocompromised , VUR) – TURBT – ESWL (in uncomplicated case & pre-op –ve c/st) – URS (diagnostic) – PCNL (when pre-op –ve c/st) – Open /lap uro intervention (clear surgery)